Publications: PROF Alastair Noyce

Torricelli R, Kenny JE, Bache E, Pérez-Carbonell L, Huxford BF, Chohan H, Leschziner G, Alty J et al. ( 2026 ) . Handwriting patterns in isolated rapid eye movement sleep behaviour disorder . Journal of Parkinson’s Disease

Okubadejo NU, Schaeffer E, Noyce AJ, Heinzel S, Burn DJ, Fung VS, Postuma RB, Berg D ( 2026 ) . Addressing Gaps in Parkinson's Disease Etiology: The Need for a Polyexposure Score . Movement Disorders

Smith LJ, Jeyaganesh J, Li X, Gill A, Schrag A, Huxford B, Simonet C, Pérez-Carbonell L et al. ( 2026 ) . The Use of a Digital Social Forum in a Parkinson’s Disease Risk Cohort: A Thematic Analysis of Forum Messages . Parkinson's Disease vol. 2026 , ( 1 )

Tolosa E, Poewe W, Noyce AJ, Svenningsson P, Mahlknecht P, Marti MJ ( 2026 ) . Towards biomarker-based diagnosis of Parkinson disease . Nature Reviews Neurology vol. 22 , ( 3 ) 139 - 151 .

Kenny J, Torricelli R, Zirra A, Boyle T, Periñán MT, Gallagher D, Budu C, Dey KC et al. ( 2026 ) . A cross-sectional exploration of the relationship between Parkinson's disease and peripheral blood immune cells in an ethnically diverse East London population . Journal of the Neurological Sciences vol. 484 ,

Bramich S, Lam A, King AE, Noyce A, Naismith SL, Pérez-Carbonell L, Vickers JC, Alty J ( 2026 ) . Circadian dysregulation in probable isolated REM sleep behaviour disorder: actigraphy insights from the Tasmanian ISLAND Sleep Study . Sleep Medicine vol. 138 ,

Bramich S, Noyce A, King AE, Roccati E, Naismith SL, Barnham K, Beauchamp LC, Vickers JC et al. ( 2026 ) . Remote unsupervised tests of isolated REM sleep behaviour disorder in the community: results from the Tasmanian ISLAND Sleep Study . Sleep Medicine vol. 138 ,

Mattjie C, Ravazio R, Mitchell E, Bestwick J, Kupssinskü LS, Noyce A, Schuh AS, Barros RC ( 2026 ) . Evaluating Odor Selectivity in α-Synucleinopathy: ML-Based Odor Profiling . Intelligent Systems , vol. 16181 , Springer Nature

Huxford B, Meyer S, Chohan H, Shahid A, Lathey R, Benabderrazik R, Noyce AJ ( 2026 ) . Feasibility of Remote Blood Collection Using Tasso+ in the PREDICT‐PD Study . Movement Disorders Clinical Practice

Fan Z, Searle G, Rizzo G, Albani J, Cella P, Comley R, Klein G, Passamonti L et al. ( 2026 ) . Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale . Annals of Neurology

Demnitz-King H, Banerjee S, Cooper C, Kenten C, Phillips R, Zabihi S, Birks Y, Brayne C et al. ( 2026 ) . The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process . Nature Reviews Neurology vol. 22 , ( 2 ) 123 - 135 .

Symes I, Jeyaruban P, Zaloum SA, Mair D, Patyjewicz M, Hashi M, Noyce AJ, Smith LJ ( 2026 ) . Social determinants of health in recreational nitrous oxide use: a narrative review . BMJ Public Health vol. 4 , ( 1 )

Durrani FG, Marshall CR, Waters S, Bishop LG, Lim DG, Smith LJ, Chemas N, Uchegbu I et al. ( 2025 ) . (DIADEM) Digital Assessment of Auditory Perception in Dementia : Study Protocol . Alzheimer's & Dementia vol. 21 , ( Suppl 2 )

Shahkhali MG, Liu L, Somerville EN, Noyce AJ, Gan-Or Z, Senkevich K ( 2025 ) . No evidence for genetic role of the tumor necrosis factor pathway in Parkinson’s disease . npj Parkinson's Disease vol. 11 , ( 1 )

Zolfaghari S, Kouchache T, Delva A, Bouhadoun S, Kuhlencord M, Pelletier A, Noyce AJ, Waters S et al. ( 2025 ) . Delayed Disease Onset Report in UK Biobank: Implications for Prodromal Studies in Parkinson's Disease . Movement Disorders

Attaallah B, Waters S, Marshall C, Noyce A ( 2025 ) . The relationship between neuropsychiatric dimensions and markers of Parkinson’s disease risk in the UK Biobank . npj Parkinson's Disease vol. 11 , ( 1 )

Grzych G, Lee GR, Alpdemir M, Gernez E, Anseeuw K, Bjorke-Monsen A-L, Croes K, El-Khoury JM et al. ( 2025 ) . Addressing the silent epidemic of recreational nitrous oxide use: a position, call to action and recommendations by the European Federation of Clinical Chemistry and Laboratory Medicine Committee on Biological Markers of Nitrous Oxide Abuse . Clinical Chemistry and Laboratory Medicine vol. 64 , ( 4 ) 813 - 820 .

Belete D, Mattjie C, Huxford B, Bestwick JP, Noyce AJ, Simonet C ( 2025 ) . Evaluating the Role of α‐Synuclein Seed Amplification as a Disease Progression Marker: Evidence and Uncertainties . Movement Disorders Clinical Practice

Markovic-Obiago Z, Bestwick JP, Chohan H, Schrag A, Simonet C, Noyce AJ ( 2025 ) . Idiopathic hyposmia as a marker of prodromal Parkinson’s disease — a cohort study . Scientific Reports vol. 15 , ( 1 )

Singleton A, Blauwendraat C, Morris HR, Noyce AJ, Klein C, Mata I, Okubadejo N, Periñan MT et al. ( 2025 ) . Parkinson's disease: emerging opportunities through global collaboration . The Lancet vol. 407 , ( 10525 ) 203 - 205 .

Bramich S, Noyce AJ, King AE, Higgins S, Simonet C, Bindoff AD, Naismith SL, Vickers JC et al. ( 2025 ) . The Tasmania-London protocol to detect isolated rapid eye movement sleep behavior disorder using home-based video-polysomnography . Sleep

Martín‐Bórnez M, Shar N, Nour MA, Murphy D, Elsayed I, Nanjundaswamy MS, Nwaokorie F, Olusanya A et al. ( 2025 ) . Does COMT Play a Role in Parkinson's Disease Susceptibility across Diverse Ancestral Populations? . Movement Disorders vol. 40 , ( 12 ) 2819 - 2824 .

Blauwendraat C, Morris HR, Van Keuren-Jensen K, Noyce AJ, Singleton AB ( 2025 ) . The temporal order of genetic, environmental, and pathological risk factors in Parkinson's disease: paving the way to prevention . The Lancet Neurology vol. 24 , ( 11 ) 969 - 975 .

Hashi M, Smith L, Patyjewicz M, Onen B, Mamigo K, Adu-poku E, Fox G, Noyce AJ ( 2025 ) . Evaluation of outcomes for patients with nitrous oxide-related myeloneuropathy treated with self-injection of hydroxocobalamin versus nurse-led injections on an ambulatory care pathway . BMJ Neurology Open vol. 7 , ( 2 )

Shafieinouri M, Hong S, Lee PS, Grant SM, Khani M, Dadu A, Schumacher Schuh AF, Makarious MB et al. ( 2025 ) . Gut-brain nexus: Mapping multimodal links to neurodegeneration at biobank scale . Science Advances vol. 11 , ( 35 )

Blauwendraat C, Noyce AJ, Mata IF, Screven LA, Solle J, Dumanis SB, Riley EA, Periñan MT et al. ( 2025 ) . Tackling a disease on a global scale, the Global Parkinson’s Genetics Program, GP2: A new generation of opportunities . American Journal of Human Genetics vol. 112 , ( 9 ) 1988 - 2000 .

Bramich S, Noyce AJ, Pérez‐Carbonell L, King AE, Naismith SL, Wang X, Bindoff A, Vickers JC et al. ( 2025 ) . Are We Asking the Right Questions? Sex Specificity of Dream Characteristics in Probable Rapid Eye Movement Sleep Behavior Disorder . Movement Disorders Clinical Practice vol. 12 , ( 12 ) 2278 - 2288 .

Azoidou V, Zirra A, Boyle T, Gallagher D, Noyce AJ, Simonet C ( 2025 ) . Usability, safety and tolerability of CUE1 vibrotactile device as promising therapeutic approach in orthostatic tremor . Clinical Parkinsonism & Related Disorders vol. 13 ,

Schade S, Ghosh S, Garrido A, Mahlknecht P, Marques TM, Horlings CGC, Jónsdóttir SR, Lang E et al. ( 2025 ) . Identifying individuals at-risk of developing Parkinson’s disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel Study . npj Parkinson's Disease vol. 11 , ( 1 )

Huxford B, Simonet C, Pérez‐Carbonell L, Leschziner G, Schrag A, Dobson R, Noyce AJ ( 2025 ) . Plasma Neurofilament Light Chain and TNF‐α Correlate with Motor Features in Isolated REM Sleep Behavior Disorder . Movement Disorders Clinical Practice vol. 12 , ( 11 ) 1961 - 1967 .

Coleman A, Touzé A, Farag M, Pengo M, Murphy MJ, Hassan Y, Thackeray O, Fayer K et al. ( 2025 ) . Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseases . Journal of Neurology vol. 272 , ( 8 )

Saffie-Awad P, Grant SM, Makarious MB, Elsayed I, Sanyaolu AO, Crea PW, Schumacher Schuh AF, Levine KS et al. ( 2025 ) . Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores . npj Parkinson's Disease vol. 11 , ( 1 )

Bramich S, Noyce AJ, King AE, Roccati E, Naismith SL, Vickers JC, Alty J ( 2025 ) . Self-testing for symptoms and signs of prodromal alpha-synucleinopathies: results from the Tasmanian ISLAND Sleep Study . GeroScience vol. 47 , ( 6 ) 6711 - 6730 .

Zirra A, Dey KC, Camboe E, Waters S, Haque T, Huxford B, Chohan H, Donkor N et al. ( 2025 ) . The East London Parkinson’s disease project – a case-control study of Parkinson’s Disease in a diverse population . npj Parkinson's Disease vol. 11 , ( 1 )

Rudd KD, Callisaya ML, Lawler K, Noyce AJ ( 2025 ) . Stepping and tapping: combining motor tasks improves cognitive classification . GeroScience1 - 14 .

Simuni T, Gochanour C, Nair AR, Brumm MC, Coffey C, Poston KL, Chahine LM, Weintraub D et al. ( 2025 ) . Neuronal α‐Synuclein Disease Stage Progression over 5 Years . Movement Disorders vol. 40 , ( 7 ) 1318 - 1330 .

Azoidou V, Bhadra E, Rowsell K, Camboe E, Dey K, Zirra A, Quah C, Budu C et al. ( 2025 ) . Non-invasive device to alleviate symptoms in people living with Parkinson’s: study protocol for a multicentre phase II double-blind randomised controlled trial . BMJ Open vol. 15 , ( 4 )

Mehanna R, Marras C, Fleisher J, Post B, Kumar KR, Noyce A, Alcalay R, Salari M et al. ( 2025 ) . Diagnostic work up when suspecting early onset Parkinson disease (EOPD). Recommendations from the MDS EOPD study group . Parkinsonism & Related Disorders vol. 135 ,

Gonzalez‐Robles C, Athauda D, Barber TR, Barker RA, Dexter DT, Duty S, Ellis‐Doyle R, Gandhi S et al. ( 2025 ) . Treatment Selection and Prioritization for the EJS ACT‐PD MAMS Trial Platform . Movement Disorders vol. 40 , ( 7 ) 1307 - 1317 .

Mitchell E, Mattjie C, Bestwick JP, Barros RC, Simonet C ( 2025 ) . Hyposmia in Parkinson’s disease; exploring selective odour loss . npj Parkinson's Disease vol. 11 , ( 1 )

Lim S-Y, all the authors, Tan AH, Ahmad-Annuar A, Okubadejo NU, Lohmann K, Morris HR, Toh TS et al. ( 2025 ) . The Genetic Epidemiology of Parkinson's Disease view – Authors' reply . The Lancet Neurology vol. 24 , ( 4 ) 285 - 286 .

Schlickmann TH, Tessari MS, Borelli WV, Pereira GM, Zimmer E, Noyce A, Mata IF ( 2025 ) . Prevalence, distribution and future projections of Parkinson disease in Brazil: insights from the ELSI-Brazil cohort study . The Lancet Regional Health - Americas vol. 44 ,

Lange LM, Levine K, Fox SH, Marras C, Ahmed N, Kuznetsov N, Vitale D, Iwaki H et al. ( 2025 ) . The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population . npj Parkinson's Disease vol. 11 , ( 1 )

Chahine LM, Lafontant D-E, Choi SH, Iwaki H, Blauwendraat C, Singleton AB, Brumm MC, Alcalay RN et al. ( 2025 ) . LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization . Brain Communications vol. 7 , ( 2 )

Zabihi S, Bestwick JP, Jitlal M, Bothongo PL, Zhang Q, Carter C, Roche M, Morgan‐Trimmer S et al. ( 2025 ) . Early presentations of dementia in a diverse population . Alzheimer's & Dementia vol. 21 , ( 2 )

Azoidou V, Rowsell K, Camboe E, Dey KC, Zirra A, Quah C, Boyle T, Gallagher D et al. ( 2025 ) . A pilot interventional study on feasibility and effectiveness of the CUE1 device in Parkinson's disease . Parkinsonism & Related Disorders vol. 133 ,

Zaloum SA, Mair D, Paris A, Smith LJ, Patyjewicz M, Onen BL, Noyce AJ ( 2025 ) . Tackling the growing burden of nitrous oxide-induced public health harms . The Lancet Public Health vol. 10 , ( 3 ) e257 - e263 .

Paris A, Amirthalingam G, Karania T, Foote IF, Dobson R, Noyce AJ, Marshall CR, Waters S ( 2025 ) . Depression and dementia: interrogating the causality of the relationship . Journal of Neurology Neurosurgery & Psychiatry vol. 96 , ( 6 ) 573 - 581 .

Wang X, Bindoff A, St George RJ, Lawler K, Noyce AJ, Bai Q, Salmon K ( 2025 ) . Tapping into a new hand‐motor biomarker of the dementia continuum ‐ integration and validation in a cognitive clinic . Alzheimer's & Dementia vol. 20 , ( Suppl 2 )

Wang X, Bindoff A, St George RJ, Roccati E, Bartlett L, Noyce AJ, Tran S ( 2025 ) . Unsupervised online reaction time test improves estimation of cognitive function in a large sample of cognitively‐asymptomatic older adults . Alzheimer's & Dementia vol. 20 , ( Suppl 2 )

Alty JE, Wang X, Bindoff A, Roccati E, Bartlett L, Lawler K, Bai Q ( 2025 ) . Using TAS Test online hand‐tapping tests to detect cognitive decline in a large community cohort of older Australians . Alzheimer's & Dementia vol. 20 , ( Suppl 2 )

Zabihi S, Bestwick JP, Bothongo PL, Zhang Q, Carter C, Roche M, Morgan‐Trimmer S, Birks Y et al. ( 2025 ) . Early presentations of dementia across cultures: Analysis of primary care data from a diverse population . Alzheimer's & Dementia vol. 20 , ( Suppl 3 )

Sanyaolu AO, Mohamed W, Makarious MB, August JL, Kekenadze M, Heilbron K, Periñán MT ( 2025 ) . Chapter 4 Mendelian randomization and Parkinson’s disease . Integrative Omics in Parkinson's Disease , Elsevier

Kim JJ, Bandres-Ciga S, Heilbron K, Blauwendraat C ( 2024 ) . Bidirectional relationship between olfaction and Parkinson’s disease . npj Parkinson's Disease vol. 10 , ( 1 )

Tan AH, Saffie-Awad P, Schuh AFS, Lim S-Y, Madoev H, Ahmad-Annuar A, Solle J, Wegel CE et al. ( 2024 ) . Global Perspectives on Returning Genetic Research Results in Parkinson Disease . Neurology Genetics vol. 10 , ( 6 )

Brolin KA, Schaeffer E, Kuri A, Schuh AFS, Darweesh SKL, Kaasinen V, Tolppanen A ( 2024 ) . Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications . Movement Disorders vol. 40 , ( 2 ) 204 - 221 .

Bramich S, Noyce A, Pérez-Carbonell L, Bindoff A, Wang X, Vickers J ( 2024 ) . P027 Dream characteristics are sex-specific in REM Sleep Behaviour Disorder and healthy older adults . SLEEP Advances vol. 5 , ( Supplement_1 ) a38 - a39 .

Mahlknecht P, Leiter S, Horlings C, Schwarzová K, Egner I, Stockner H, Marini K, Theyer C et al. ( 2024 ) . Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based Study . Movement Disorders Clinical Practice vol. 12 , ( 2 ) 203 - 209 .

Azoidou V, Noyce AJ ( 2024 ) . The effect of tactile cueing on dual task performance in Parkinson’s disease. A systematic review and meta-analysis . Clinical Parkinsonism & Related Disorders vol. 11 ,

Hernández CS, Torricelli R, Kenny J, Bache E, Carbonell LP, Huxford B, Leschziner G, Schrag A et al. ( 2024 ) . 21493. CARACTERÍSTICAS DE LA ESCRITURA EN PACIENTES CON TRASTORNO DE CONDUCTA DEL SUEÑO REM . Neurology Perspectives vol. 4 ,

Step K, Eltaraifee E, Elsayed I, Rasaholiarison N, Okubadejo N, Walker R, Mohamed W, Rizig M et al. ( 2024 ) . Advancing Parkinson's Disease Research in Africa: A Strategic Training Framework of the Global Parkinson's Genetics Program . Movement Disorders vol. 40 , ( 1 ) 51 - 56 .

Lim S-Y, Tan AH, Ahmad-Annuar A, Okubadejo NU, Lohmann K, Morris HR, Toh TS, Tay YW et al. ( 2024 ) . Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic . The Lancet Neurology vol. 23 , ( 12 ) 1267 - 1280 .

Pereira GM, Teixeira-dos-Santos D, Soares NM, Marconi GA, Friedrich DC, Saffie Awad P, Santos-Lobato BL, Brandão PRP et al. ( 2024 ) . A systematic review and meta-analysis of the prevalence of Parkinson’s disease in lower to upper-middle-income countries . npj Parkinson's Disease vol. 10 , ( 1 )

Tanner C, Galasko D, Chahine L, Poston K, Dobkin R, Dan Weintraub, Brown E, Alcalay R et al. ( 2024 ) . Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts . npj Parkinson's Disease vol. 10 , ( 1 )

Touze A, Coleman A, Farag M, Pengo M, Murphy MJ, Hassan Y, Thackeray O, Fayer K et al. ( 2024 ) . D019 Validation of remote collection and quantification of blood neurofilament light in neurological diseases . Conference: D: Wet biomarkersa43 - a44 .

Joerres C, Patyjewicz M, Cetin M, Bariana T, Onen B, Hone L, Green J ( 2024 ) . Assessing the prevalence of nitrous oxide usage in patients aged 35 years or under presenting with unprovoked VTE between 2021-2023 . Thrombosis Update vol. 16 ,

Araújo R, Noyce AJ, Bloem BR ( 2024 ) . Therapeutic ancillary examinations in clinical neurology . Journal of Neurology vol. 271 , ( 10 ) 7026 - 7029 .

Lázaro‐Figueroa A, Hernández‐Medrano AJ, Ramírez‐Pineda DB, Cadavid AN, Makarious M, Foo JN, Alvarado CX, Bandres‐Ciga S et al. ( 2024 ) . Is SH3GL2 p.G276V the Causal Functional Variant Underlying Parkinson's Disease Risk at this Locus? . Movement Disorders vol. 39 , ( 11 ) 2117 - 2119 .

Rudd KD, Lawler K, Callisaya ML, Bindoff AD, Chiranakorn-Costa S, Li R, McDonald JS, Vickers JC ( 2024 ) . Hand Motor Dysfunction Is Associated with Both Subjective and Objective Cognitive Impairment across the Dementia Continuum . Dementia and Geriatric Cognitive Disorders vol. 54 , ( 1 ) 10 - 20 .

Schaeffer E, Yilmaz R, St. Louis EK ( 2024 ) . Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review . Journal of Parkinson’s Disease vol. 14 , ( s2 ) s307 - s319 .

Francis M, Zirra A, Haque T, Gallagher D, Budu C ( 2024 ) . Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease . Journal of Parkinson’s Disease vol. 14 , ( 5 ) 993 - 997 .

Zhang Q, Noyce AJ, Robson J, Giovannoni G, Marshall CR, Dobson R ( 2024 ) . No association between oral contraceptive exposure and subsequent MS: A population-based nested case–control study in primary care . Multiple Sclerosis Journal vol. 30 , ( 9 ) 1221 - 1226 .

Zaloum SA, Paris A, Mair D, Gutteridge C, Onen BL, Workman A, Villanueva N ( 2024 ) . Evaluation of an ambulatory care pathway for patients with nitrous oxide-induced myeloneuropathy . BMJ Neurology Open vol. 6 , ( 1 )

Li X, Gill A, Panzarasa P, Bestwick J, Noyce A ( 2024 ) . Web Application to Enable Online Social Interactions in a Parkinson Disease Risk Cohort: Feasibility Study and Social Network Analysis . JMIR Formative Research vol. 8 ,

Rees RN, Noyce AJ ( 2024 ) . Identification of Prodromal Parkinson Disease . Neurology vol. 102 , ( 11 )

Patyjewicz M, Mair D, Zaloum SA, Onen B, Walton J, Dobson R, Joerres C, Shah AM et al. ( 2024 ) . Recreational nitrous oxide and thrombotic events: a case series . BMJ Neurology Open vol. 6 , ( 1 )

Gernez E, Alpdemir M, Anseeuw K, Monsen AB, Khoury JE, Lee G, Noyce A, Vermeersch P ( 2024 ) . Strategic collaboration to address nitrous oxide challenges: Establishment of an international consortium of experts . Clinica Chimica Acta vol. 558 ,

Badenoch JB, Paris A, Jacobs BM, Noyce AJ, Marshall CR, Waters S ( 2024 ) . Neuroanatomical and prognostic associations of depression in Parkinson’s disease . Journal of Neurology Neurosurgery & Psychiatry vol. 95 , ( 10 )

Chang Y-H, Periñan MT, Wilson M ( 2024 ) . AccessPD as a next generation registry to accelerate Parkinson’s disease research . npj Parkinson's Disease vol. 10 , ( 1 )

Simonet C, Pérez‐Carbonell L, Galmés‐Ordinas MA, Huxford BFR, Chohan H, Gill A, Leschziner G ( 2024 ) . The Motor Dysfunction Seen in Isolated REM Sleep Behavior Disorder . Movement Disorders vol. 39 , ( 6 ) 1054 - 1059 .

Ojo OO, Bandres‐Ciga S, Makarious MB, Crea PW, Hernandez DG, Houlden H, Rizig M, Singleton AB ( 2024 ) . GBA1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians . Movement Disorders vol. 39 , ( 4 ) 728 - 733 .

Lucas A, Noyce AJ, Gernez E, Khoury JME, Garcon G ( 2024 ) . Nitrous oxide abuse direct measurement for diagnosis and follow-up: update on kinetics and impact on metabolic pathways . Clinical Chemistry and Laboratory Medicine vol. 62 , ( 12 ) 2356 - 2372 .

Reynoso A, Torricelli R, Jacobs BM, Shi J, Aslibekyan S, Norcliffe‐Kaufmann L, Noyce AJ, Heilbron K ( 2024 ) . Gene–Environment Interactions for Parkinson's Disease . Annals of Neurology vol. 95 , ( 4 ) 677 - 687 .

Kim JJ, Vitale D, Otani DV, Lian MM, Heilbron K, Iwaki H, Lake J, Solsberg CW et al. ( 2023 ) . Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease . Nature Genetics vol. 56 , ( 1 ) 27 - 36 .

Foote IF, Bandres‐Ciga S, Kim JJ, Alvarado CX, Leonard HL, Bothongo PL, Grotzinger AD, Jacobs BM et al. ( 2023 ) . A Multivariate Genome‐Wide Association Study of the Shared Genetic Architecture Among Modifiable Risk Factors for Dementia: 590 Loci Associated with Brain Health . Alzheimer's & Dementia vol. 19 , ( S22 )

Bramich S, King AE, Noyce AJ, Bindoff AD, Kuruvilla M ( 2023 ) . Isolated REM sleep behaviour disorder in the Tasmanian ISLAND Sleep Study: prevalence and profiles of prodromal dementia . Alzheimer's & Dementia vol. 19 , ( S14 )

Bramich S, King AE, Noyce AJ, Bindoff AD, Naismith SL, Vickers JC ( 2023 ) . Tasmanian ISLAND Sleep Study: prodromal neurodegenerative disease (iRBD) is associated with subjective reports of daytime sleepiness and poor sleep quality . Alzheimer's & Dementia vol. 19 , ( S14 )

Gonzalez‐Robles C, Burnell M, Clarke CS, Haar S, Hu MT, Huxford B, Jha A, Lawton M et al. ( 2023 ) . Embedding Patient Input in Outcome Measures for Long‐Term Disease‐Modifying Parkinson Disease Trials . Movement Disorders vol. 39 , ( 2 ) 433 - 438 .

Gernez E, Lucas A, Niguet J, Bennis A, Grzych G ( 2023 ) . What biological markers could be used for diagnosis and monitoring of nitrous oxide abuse? . European Journal of Neurology vol. 31 , ( 3 )

Bramich S, Noyce AJ, King AE, Naismith SL, Kuruvilla MV, Lewis SJG, Roccati E, Bindoff AD et al. ( 2023 ) . Isolated rapid eye movement sleep behaviour disorder (iRBD) in the Island Study Linking Ageing and Neurodegenerative Disease (ISLAND) Sleep Study: protocol and baseline characteristics . Journal of Sleep Research vol. 33 , ( 3 )

Toffoli M, Chohan H, Mullin S, Yalkic S, Koletsi S, Menozzi E, Rahall S, Limbachiya N et al. ( 2023 ) . Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study . Neurobiology of Disease vol. 188 ,

Mair D, Zaloum SA, Patel F ( 2023 ) . Effectiveness of interactive workshops to raise awareness of the neurological harms associated with nitrous oxide use: a cross-sectional study . The Lancet vol. 402 ,

Bernard Healey SA, Giovannoni G, Noyce A, Dobson R, Jacobs BM ( 2023 ) . Impact of multiple sclerosis risk alleles on the plasma proteome . Brain vol. 147 , ( 2 ) e17 - e21 .

Paris A, Mair D, Onen B ( 2023 ) . Nitrous oxide and its neurological harms . The Lancet Neurology vol. 22 , ( 10 )

Lange LM, Avenali M, Ellis M, Illarionova A, Keller Sarmiento IJ, Tan A-H, Madoev H, Galandra C et al. ( 2023 ) . Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) . npj Parkinson's Disease vol. 9 , ( 1 )

Towns C, Richer M, Jasaityte S, Stafford EJ, Joubert J, Antar T, Martinez-Carrasco A, Makarious MB et al. ( 2023 ) . Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2) . npj Parkinson's Disease vol. 9 , ( 1 )

Gonzalez-Robles C, Weil RS, van Wamelen D, Bartlett M, Burnell M, Clarke CS, Hu MT, Huxford B et al. ( 2023 ) . Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative . Journal of Parkinson’s Disease vol. 13 , ( 6 ) 1011 - 1033 .

Jacobs BM, Tank P, Bestwick JP, Noyce AJ, Marshall CR, Mathur R, Giovannoni G, Dobson R ( 2023 ) . Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case–control study in an English population-based cohort . Journal of Neurology vol. 271 , ( 1 ) 241 - 253 .

Rizig M, Bandres-Ciga S, Makarious MB, Ojo OO, Crea PW, Abiodun OV, Levine KS, Abubakar SA et al. ( 2023 ) . Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study . The Lancet Neurology vol. 22 , ( 11 ) 1015 - 1025 .

LIU H, Dehestani M, Blauwendraat C, Makarious MB, Leonard H, Kim JJ, Schulte C, Noyce A et al. ( 2023 ) . Polygenic resilience inheritance modulates the penetrance of Parkinson’s disease genetic risk factors . Parkinsonism & Related Disorders vol. 113 ,

Wang X, St George RJ, Bindoff AD, Noyce AJ, Lawler K, Roccati E, Bartlett L ( 2023 ) . Estimating presymptomatic episodic memory impairment using simple hand movement tests: A cross‐sectional study of a large sample of older adults . Alzheimer's & Dementia vol. 20 , ( 1 ) 173 - 182 .

Simonet C, Mahlknecht P, Marini K, Seppi K, Gill A, Lees AJ, Giovannoni G, Schrag A ( 2023 ) . The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease . Movement Disorders vol. 38 , ( 9 ) 1636 - 1644 .

Mair D, Paris A, Zaloum SA, White LM, Englezou C, Patel F, Lilleker JB, Gosal D et al. ( 2023 ) . Nitrous oxide-induced myeloneuropathy: a case series . Journal of Neurology Neurosurgery & Psychiatry vol. 94 , ( 9 ) 681 - 688 .

Leonard HL, Murtadha R, Martinez-Carrasco A, Jama A, Müller-Nedebock AC, Gil-Martinez A-L, Illarionova A, Moore A et al. ( 2023 ) . Author Correction: The IPDGC/GP2 Hackathon - an open science event for training in data science, genomics, and collaboration using Parkinson’s disease data . npj Parkinson's Disease vol. 9 , ( 1 )

Jacobs BM, Schalk L, Dunne A, Scalfari A, Nandoskar A, Gran B, Mein CA, Sellers C et al. ( 2023 ) . ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK . BMJ Open vol. 13 , ( 5 )

Senkevich K, Alipour P, Chernyavskaya E, Noyce AJ ( 2023 ) . Potential Protective Link Between Type I Diabetes and Parkinson's Disease Risk and Progression . Movement Disorders vol. 38 , ( 7 ) 1350 - 1355 .

Pérez‐Carbonell L, Simonet C, Chohan H, Gill A, Leschziner G ( 2023 ) . The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure . Movement Disorders vol. 38 , ( 6 ) 1089 - 1093 .

Alvarez Jerez P, Alcantud JL, de los Reyes-Ramírez L, Moore A, Ruz C, Vives Montero F, Rodriguez-Losada N, Saini P et al. ( 2023 ) . Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease . npj Parkinson's Disease vol. 9 , ( 1 )

Leonard HL, Murtadha R, Martinez-Carrasco A, Jama A, Müller-Nedebock AC, Gil-Martinez A-L, Illarionova A, Moore A et al. ( 2023 ) . The IPDGC/GP2 Hackathon - an open science event for training in data science, genomics, and collaboration using Parkinson’s disease data . npj Parkinson's Disease vol. 9 , ( 1 )

Foltynie T, Gandhi S, Gonzalez-Robles C, Zeissler M-L, Mills G, Barker R, Carpenter J, Schapira A et al. ( 2023 ) . Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease . Brain vol. 146 , ( 7 ) 2717 - 2722 .

Paris A, Lake L, Joseph A, Workman A, Walton J, Hayton T, Lilleker JB, Ayling RM ( 2023 ) . Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment . Practical Neurology vol. 23 , ( 3 ) 222 - 228 .

Belete D, Jacobs BM, Simonet C, Bestwick JP, Waters S, Marshall CR, Dobson R, Noyce AJ ( 2023 ) . Association Between Antiepileptic Drugs and Incident Parkinson Disease . JAMA Neurology vol. 80 , ( 2 ) 183 - 187 .

Nagy AV, Leschziner G, Eriksson SH, Lees A ( 2023 ) . Cognitive impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson's disease . Parkinsonism & Related Disorders vol. 109 ,

Frisoni GB, Altomare D, Ribaldi F, Villain N, Brayne C, Mukadam N, Abramowicz M, Barkhof F et al. ( 2023 ) . Dementia prevention in memory clinics: recommendations from the European task force for brain health services . The Lancet Regional Health - Europe vol. 26 ,

Bramich S, Verdi K, Salmon K, Noyce A ( 2022 ) . REM sleep behaviour disorder: the importance of early identification in primary care . British Journal of General Practice vol. 73 , ( 726 ) 40 - 42 .

Dadu A, Satone V, Kaur R, Hashemi SH, Leonard H, Iwaki H, Makarious MB, Billingsley KJ et al. ( 2022 ) . Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts . npj Parkinson's Disease vol. 8 , ( 1 )

Krohn L, Heilbron K, Blauwendraat C, Reynolds RH, Yu E, Senkevich K, Rudakou U, Estiar MA et al. ( 2022 ) . Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects . Nature Communications vol. 13 , ( 1 )

Zirra A, Rao SC, Bestwick J, Marras C, Blauwendraat C ( 2022 ) . Gender Differences in the Prevalence of Parkinson's Disease . Movement Disorders Clinical Practice vol. 10 , ( 1 ) 86 - 93 .

Periñán MT, Brolin K, Bandres‐Ciga S, Blauwendraat C, Klein C, Gan‐Or Z, Singleton A, Swanberg M ( 2022 ) . Effect Modification between Genes and Environment and Parkinson's Disease Risk . Annals of Neurology vol. 92 , ( 5 ) 715 - 724 .

Jacobs BM, Peter M, Giovannoni G, Noyce AJ, Morris HR, Dobson R ( 2022 ) . Towards a global view of multiple sclerosis genetics . Nature Reviews Neurology vol. 18 , ( 10 ) 613 - 623 .

Kent DM, Leung LY, Puttock EJ, Wang AY, Luetmer PH, Kallmes DF, Zheng C, Vickery EM ( 2022 ) . Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real‐World Cohort . Annals of Neurology vol. 92 , ( 4 ) 620 - 630 .

Paris A, Amirthalingam G, Karania T, Dey S, Foote I, Bothongo P, Dobson R, Noyce A et al. ( 2022 ) . 043 Depression is associated with increased dementia risk and reduced grey matter in a fronto-insular-cerebellar network . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 9 )

Zirra A, Ben-Joseph A, Haque T, Gallagher D, Budu C, Frances B, Noyce A ( 2022 ) . 091 The East London Parkinson’s disease project – engaging a diverse population in research . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 9 )

Rees R, Philpot C, McLelland L, Gill A, Simonet C-T, Noyce A ( 2022 ) . 096 Motor and non-motor features of prodromal Parkinson’s in idiopathic anosmia . Journal of Neurology Neurosurgery & Psychiatry . vol. 93 ,

Rees R, Gill A, Giovannoni G, Lees A, Noyce AJ ( 2022 ) . 097 Transcranial sonography in the prodromal phase of PD . Journal of Neurology Neurosurgery & Psychiatry . vol. 93 ,

Rees R, Simonet C, Gill A, Giovannoni G, Bestwick J, Lees A ( 2022 ) . 101 Motor and non-motor features of prodromal PD . Journal of Neurology Neurosurgery & Psychiatry . vol. 93 ,

Zirra A, Rao S, Bestwick J, Rajalingam R, Blau-Wendraat C ( 2022 ) . 104 Examining the sex differences in the prevalence and incidence of Parkinson disease . Journal of Neurology Neurosurgery & Psychiatry . vol. 93 ,

Jacobs B, Giovannoni G, Noyce A, Morris H, Dobson R ( 2022 ) . 121 The ADAMS project: protocol and baseline results . Journal of Neurology Neurosurgery & Psychiatry . vol. 93 ,

Simonet C, Bestwick J, Jitlal M, Waters S, Ben-Joseph A, Mar-Shall CR, Dobson R, Jacobs BM et al. ( 2022 ) . Risk factors and Parkinson’s disease presentations in primary care in a diverse UK population . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 9 )

Chohan H, Simonet C, Gill A, Schrag A, Pérez-Carbonell L ( 2022 ) . What, when and how should the information about neurodegenerative disease risk in iRBD be communicated? . Journal of Neurology Neurosurgery & Psychiatry . vol. 93 ,

Schumacher‐Schuh AF, Bieger A, Okunoye O, Mok KY, Lim S, Bardien S, Ahmad‐Annuar A, Santos‐Lobato BL et al. ( 2022 ) . Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions . Movement Disorders vol. 37 , ( 8 ) 1593 - 1604 .

Day JO, Smith S, Noyce AJ, Jeffery A ( 2022 ) . Challenges of Incorporating Digital Health Technology Outcomes in a Clinical Trial: Experiences from PD STAT . Journal of Parkinson’s Disease vol. 12 , ( 5 ) 1605 - 1609 .

Bramich S, King A, Kuruvilla M, Naismith SL ( 2022 ) . Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies . Journal of Neurology vol. 269 , ( 9 ) 4684 - 4695 .

Liu H, Dehestani M, Blauwendraat C, Makarious MB, Leonard H, Kim JJ, Schulte C, Noyce A et al. ( 2022 ) . Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors . Annals of Neurology vol. 92 , ( 2 ) 270 - 278 .

Foote IF, Jacobs BM, Mathlin G, Watson CJ, Bothongo PL, Waters S, Dobson R, Noyce AJ et al. ( 2022 ) . The shared genetic architecture of modifiable risk for Alzheimer's disease: a genomic structural equation modelling study . Neurobiology of Aging vol. 117 , 222 - 235 .

Watson C, Waters S, Jacobs B, Foote I, Dey S, Noyce A, Marshall C ( 2022 ) . 003  Neuroanatomical signatures of genetic risk for Alzheimer’s disease in healthy adults . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a101.3 - a1a102 .

Jacobs B, Noyce A, Bestwick J, Belete D, Giovannoni G, Dobson R ( 2022 ) . 026  Gene-environment interactions in multiple sclerosis: a UK Biobank study . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a21.3 - a2a22 .

Simonet C, Bestwick J, Schrag A ( 2022 ) . 030  Emerging parkinsonism in the PREDICT-PD cohort after 5-year follow-up . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a110.2 - a1a110 .

Auger S, Kanavou S, Lawton M, Ben-Shlomo Y, Schrag A, Morris H ( 2022 ) . 228  Testing shortened versions of smell tests to screen for hyposmia in Parkinson’s disease . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a79.2 - a7a79 .

Li H, Ismail A, Castrejon-Pita R ( 2022 ) . 229  Developing novel smell test for Parkinson’s disease using microencapsulation of essential oils in alginate . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a79.3 - a7a79 .

Rees RN, Simonet C, Noyce AJ ( 2022 ) . 244  Idiopathic anosmia with motor impairment – a unique prodrome of Parkinson’s? . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a83.4 - a8a84 .

Simonet C, Lambert C, Rees R, Galmes MA ( 2022 ) . 249  Slow motion analysis of repetitive tapping (SMART) test: a new measurement of bradykinesia . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a85.2 - a8a85 .

Bothongo P, Jitlal M, Parry E, Foote I, Waters S, Dobson R, Noyce A, Bestwick J et al. ( 2022 ) . Ethnic and socioeconomic determinants of dementia risk: a nested case-con- trol study in East London . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a8.2 - a8a8 .

Jensen M, Jacobs B, Dobson R, Bandres-Ciga S, Blauwendraat C, Schrag A, Noyce A ( 2022 ) . Lower lymphocyte count is associated with increased risk of Parkinson’s disease . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a94.3 - a9a95 .

Belete D, Jacobs BM, Bestwick JP, Dobson R, Hardy J, Giovannoni G, Lees A, Schrag A et al. ( 2022 ) . Parkinson’s disease determinants, prediction and gene-environment interac- tions: a UK Biobank study . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a7.3 - a7a8 .

Watson CJ, Waters S, Jacobs BM, Foote IF, Dey S, Noyce AJ, Hardy CJD, Marshall CR ( 2022 ) . Speech-in-noise perception is a marker of preclinical Alzheimer’s disease . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a91.1 - a9a91 .

Jensen M, Heilbron K, Bandres-Ciga S, Fontanillas P, Blauwendraat C, Nalls M, Smith GD ( 2022 ) . Unhealthy traits and risk of Parkinson’s disease: a mendelian randomisation study . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a8.3 - a8a9 .

Hone L, Jacobs BM, Marshall C, Giovannoni G, Noyce A, Dobson R ( 2022 ) . Age-specific effects of childhood body mass index on multiple sclerosis risk . Journal of Neurology vol. 269 , ( 9 ) 5052 - 5060 .

Simonet C, Bestwick J, Jitlal M, Waters S, Ben-Joseph A, Marshall CR, Dobson R, Marrium S et al. ( 2022 ) . Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population . JAMA Neurology vol. 79 , ( 4 ) 359 - 369 .

Marshall CR, Noyce AJ, Neligan A, Dobson R ( 2022 ) . Brain health: The hidden casualty of a humanitarian crisis . The Lancet Regional Health - Europe vol. 15 ,

Jacobs BM, Watson C, Marshall C, Noyce A, Dobson R ( 2022 ) . No evidence for association between polygenic risk of multiple sclerosis and MRI phenotypes in ~30,000 healthy adult UK Biobank participants . Multiple Sclerosis Journal vol. 28 , ( 10 ) 1656 - 1657 .

Goodwin GR, Bestwick JP ( 2022 ) . The potential utility of smell testing to screen for neurodegenerative disorders . Expert Review of Molecular Diagnostics vol. 22 , ( 2 ) 139 - 148 .

Cornejo‐Olivas M, Wu L ( 2022 ) . Disruption of Mitochondrial Complex I Induces Progressive Parkinsonism . Movement Disorders vol. 37 , ( 3 ) 478 - 478 .

Bothongo PLK, Jitlal M, Parry E, Waters S, Foote IF, Watson CJ, Cuzick J, Giovannoni G et al. ( 2022 ) . Dementia risk in a diverse population: A single-region nested case-control study in the East End of London . The Lancet Regional Health - Europe vol. 15 ,

Goh ZHK, Cheong JLY, Marras C, Tanner CM, Kasten M, Korczyn AD, Lo R, Noyce AJ ( 2022 ) . Surveying Global Availability of Parkinson’s Disease Treatment . Journal of Parkinson’s Disease vol. 12 , ( 3 ) 1023 - 1034 .

Waters S, Watson C, Jacobs BM, Foote IF, Dey S, Noyce AJ, Marshall CR ( 2022 ) . Neuroanatomical signatures of genetic risk for Alzheimer's disease in healthy adults . Alzheimer's & Dementia vol. 17 , ( S4 )

Dobson R, Marshall C, Noyce A ( 2022 ) . Social determinants of neurological disease: tackling inequalities . The Lancet Neurology vol. 21 , ( 2 ) 122 - 123 .

Akram N, Li H, Ben-Joseph A, Budu C, Gallagher DA, Bestwick JP, Schrag A, Noyce AJ et al. ( 2022 ) . Developing and assessing a new web-based tapping test for measuring distal movement in Parkinson’s disease: a Distal Finger Tapping test . Scientific Reports vol. 12 , ( 1 )

Mitchell E, Chohan H, Bestwick JP ( 2022 ) . Alcohol and Parkinson’s Disease: A Systematic Review and Meta-Analysis . Journal of Parkinson’s Disease vol. 12 , ( 8 ) 2369 - 2381 .

Ganesh S, Huxford B, Zirra A, Edwards C, Haque T, Gallagher D, Budu C, Dobson R ( 2022 ) . Blood neurofilament light chain as a biomarker of Parkinson's disease . MOVEMENT DISORDERS . vol. 37 , S652 - S652 .

Gonzalez-Robles C, Bartlett M, Burnell M, Chaudhuri R, Clarke C, Ellis-Doyle R, Hu M, Huxford B et al. ( 2022 ) . Challenges in Outcome Measure Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease . MOVEMENT DISORDERS . vol. 37 , S329 - S329 .

Huxford B, Simonet C, Carbonell L, Zirra A, Vickaryous N, Gill A, Dobson R ( 2022 ) . Dried blood and plasma spots for the measurement of neurofilament light chain and inflammatory cytokines in patients with REM sleep behaviour disorder . MOVEMENT DISORDERS . vol. 37 , S653 - S653 .

Senkevich K, Alipour P, Chernyavskaya E, Yu E, Noyce A ( 2022 ) . Evidence of a causal relationship between Parkinson's disease and autoimmune disorders driven by HLA . EUROPEAN JOURNAL OF NEUROLOGY . vol. 29 , 307 - 308 .

Zirra A, Rao S, Bestwick J, Rajalingam R, Blauwendraat C, Mata I ( 2022 ) . Examining the sex differences in the prevalence and incidence of Parkinson disease . MOVEMENT DISORDERS . vol. 37 , S30 - S30 .

Dey S, Noyce A, Bale C, Kuhl M, Leonard H, Lewis P, Stott S, Callanan J et al. ( 2022 ) . GP2: Growing a research community in the Parkinson's disease genetics field through training and networking . MOVEMENT DISORDERS . vol. 37 , S564 - S564 .

Jacobs BM, Tank P, Bestwick JP, Noyce A, Marshall C, Giovannoni G, Dobson R ( 2022 ) . Modifiable Risk Factors for Multiple Sclerosis are Consistent Across Diverse Ethnic Backgrounds: A Nested Case-Control Study in a UK Population-Based Cohort .

Simonet C, Perez-Carbonell L, Chohan H, Akram N, Li H, Bestwick J, Lees A ( 2022 ) . Remote keyboard tapping: potential signatures of early motor dysfunction in isolated REM sleep behaviour disorder . MOVEMENT DISORDERS . vol. 37 , S379 - S379 .

Zirra A, Ben-Joseph A, Haque T, Simonet C, Noyce A ( 2022 ) . The East London Parkinson Disease Project - engaging a diverse population in research . MOVEMENT DISORDERS . vol. 37 , S29 - S30 .

Chohan H, Gill A, Schrag A, Noyce A ( 2022 ) . What, when and how should the information on iRBD and risk of Parkinson's disease and related conditions be communicated? . MOVEMENT DISORDERS . vol. 37 , S622 - S622 .

Waters S, Watson C, Jacobs BM, Foote IF, Dey S, Noyce AJ, Marshall CR ( 2021 ) . Speech‐in‐noise perception is a marker of preclinical Alzheimer’s disease . Alzheimer's & Dementia vol. 17 , ( S5 )

Storm CS, Kia DA, Almramhi MM, Bandres-Ciga S, Finan C, Hingorani AD, Wood NW ( 2021 ) . Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome . Nature Communications vol. 12 , ( 1 )

Bestwick JP, Auger SD, Simonet C, Rees RN, Rack D, Lees AJ ( 2021 ) . Improving estimation of Parkinson’s disease risk—the enhanced PREDICT-PD algorithm . npj Parkinson's Disease vol. 7 , ( 1 )

Huxford B, Haque T, Joseph AB, Simonet C, Gallagher D, Budu C, Dobson R, Noyce A ( 2021 ) . Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity . Movement Disorders vol. 37 , ( 2 ) 427 - 428 .

Foote I, Jacobs B, Watson C, Bothongo P, Waters S, Dobson R, Noyce A, Bhui K et al. ( 2021 ) . W26. A MULTIVARIATE GENOME-WIDE ASSOCIATION STUDY OF MODIFIABLE RISK FOR ALZHEIMER'S DISEASE: 269 LOCI ASSOCIATED WITH BRAIN HEALTH . European Neuropsychopharmacology vol. 51 ,

Bestwick JP, Auger SD, Schrag AE, Grosset DG, Kanavou S, Giovannoni G, Lees AJ, Noyce AJ ( 2021 ) . Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features . npj Parkinson's Disease vol. 7 , ( 1 )

Hone L, Jacobs BM, Marshall C, Giovannoni G, Noyce A, Dobson R ( 2021 ) . Age-specific effects of childhood Body Mass Index on multiple sclerosis risk .

Dey S, Noyce A, Bale C, Kuhl M, Leonard H, Lewis P, Stott S, Adams S et al. ( 2021 ) . GP2: training the next generation of Parkinson's disease genetics researchers - wherever they are in the world . MOVEMENT DISORDERS . Conference: MDS International Congress 2021 from: 22/09/2021 to: 17/09/2021 , vol. 36 , S308 - S308 .

Noyce A, Beccano-Kelly D, Bandres-Ciga S, Siddiqi B ( 2021 ) . Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities . Physiology News ( Autumn 123 )

Simonet C, Noyce AJ ( 2021 ) . Domotics, Smart Homes, and Parkinson’s Disease . Journal of Parkinson’s Disease vol. 11 , ( s1 ) s55 - s63 .

Heilbron K, Jensen MP, Bandres-Ciga S, Fontanillas P, Blauwendraat C, Smith GD, Noyce AJ ( 2021 ) . Unhealthy Behaviours and Risk of Parkinson’s Disease: A Mendelian Randomisation Study . Journal of Parkinson’s Disease vol. 11 , ( 4 ) 1981 - 1993 .

Simonet C ( 2021 ) . Mild parkinsonian signs: the interface between aging and Parkinson’s disease . Advances in Clinical Neuroscience & Rehabilitation vol. 20 ,

Gialluisi A, Reccia MG, Modugno N, Nutile T, Lombardi A, Di Giovannantonio LG, Pietracupa S, Ruggiero D et al. ( 2021 ) . Identification of sixteen novel candidate genes for late onset Parkinson’s disease . Molecular Neurodegeneration vol. 16 , ( 1 )

Jacobs BM, Noyce AJ, Bestwick J, Belete D, Giovannoni G, Dobson R ( 2021 ) . Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study . Neurology Neuroimmunology & Neuroinflammation vol. 8 , ( 4 )

Blauwendraat C, Iwaki H, Makarious MB, Bandres‐Ciga S, Leonard HL, Grenn FP, Lake J, Krohn L et al. ( 2021 ) . Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease . Annals of Neurology vol. 90 , ( 1 ) 35 - 42 .

Estiar MA, Senkevich K, Yu E, Varghaei P, Krohn L, Bandres‐Ciga S, Noyce AJ ( 2021 ) . Lack of Causal Effects or Genetic Correlation between Restless Legs Syndrome and Parkinson's Disease . Movement Disorders vol. 36 , ( 8 ) 1967 - 1972 .

Bandres-Ciga S, Saez-Atienzar S, Kim JJ, Makarious MB, Faghri F, Diez-Fairen M, Iwaki H, Leonard H et al. ( 2021 ) . Correction to: Large‑scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease . Acta Neuropathologica vol. 142 , ( 1 ) 223 - 224 .

Jitlal M, Amirthalingam NK, Karania T, Parry E, Neligan A, Dobson R, Noyce AJ, Marshall CR ( 2021 ) . The Influence of Socioeconomic Deprivation on Dementia Mortality, Age at Death, and Quality of Diagnosis: A Nationwide Death Records Study in England and Wales 2001–2017 . Journal of Alzheimer’s Disease vol. 81 , ( 1 ) 321 - 328 .

Ismail AS, Goodwin GR, Castrejon-Pita JR, Noyce AJ, Azevedo HS ( 2021 ) . A novel capsule-based smell test fabricated via coaxial dripping . Journal of The Royal Society Interface vol. 18 , ( 177 )

Senkevich K, Bandres-Ciga S, Yu E, Liyanage UE, Consortium IPDG, Gan-Or Z ( 2021 ) . No Evidence for a Causal Relationship Between Cancers and Parkinson’s Disease . Journal of Parkinson’s Disease vol. 11 , ( 2 ) 801 - 809 .

Kia DA, Zhang D, Guelfi S, Manzoni C, Hubbard L, Reynolds RH, Botía J, Ryten M et al. ( 2021 ) . Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets . JAMA Neurology vol. 78 , ( 4 ) 464 - 472 .

Chen Z, Zhang D, Reynolds RH, Gustavsson EK, D’Sa K, Fairbrother-Browne A, Vandrovcova J, Hardy J et al. ( 2021 ) . Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage . Nature Communications vol. 12 , ( 1 )

Mann I, Noyce A ( 2021 ) . The Finalist’s Guide to Passing the OSCE, Clinical Examinations and Procedures . Taylor & Francis

Bestwick JP, Auger SD, Simonet C, Rees RN, Rack D, Jitlal M, Lees AJ, Cuzick J ( 2021 ) . Improving estimation of Parkinson’s disease risk—the enhanced PREDICT-PD algorithm . npj Parkinson's Disease vol. 7 , ( 1 )

Chohan H, Senkevich K, Patel RK, Bestwick JP, Jacobs BM, Ciga SB, Gan‐Or Z, Noyce AJ ( 2021 ) . Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression . Movement Disorders vol. 36 , ( 6 ) 1420 - 1429 .

Foote IF, Jacobs BM, Mathlin G, Watson CJ, Bothongo PL, Waters S, Dobson R, Noyce AJ et al. ( 2021 ) . The Genetic Architecture of Alzheimer’s Disease Risk: A Genomic Structural Equation Modelling Study .

Jensen MP, Jacobs BM, Dobson R, Bandres‐Ciga S, Blauwendraat C, Schrag A, Noyce AJ, Consortium TIPDG ( 2021 ) . Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease . Annals of Neurology vol. 89 , ( 4 ) 803 - 812 .

Kang X, Ploner A, Pedersen NL, Bandres-Ciga S, Williams DM ( 2021 ) . Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study . Neurology vol. 96 , ( 12 ) e1672 - e1679 .

Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C ( 2021 ) . Infection and Risk of Parkinson’s Disease . Journal of Parkinson’s Disease vol. 11 , ( 1 ) 31 - 43 .

Program TGPG ( 2021 ) . GP2: The Global Parkinson's Genetics Program . Movement Disorders vol. 36 , ( 4 ) 842 - 851 .

Hone L, Jacobs B, Noyce A, Dobson R ( 2021 ) . Age-specific effects of childhood BMI on multiple sclerosis risk: a Mendelian Randomisation study . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 764 - 765 .

Simonet C, Gill A, Bestwick J, Giovannoni G ( 2021 ) . Emerging parkinsonism in the PREDICT-PD cohort after 6-years of follow-up . MOVEMENT DISORDERS . vol. 36 , S78 - S79 .

Goh ZHK, Cheong JLY, Marras C, Kasten M, Korczyn A, Noyce A ( 2021 ) . Global access to Parkinson's disease treatment . MOVEMENT DISORDERS . vol. 36 , S212 - S212 .

Huxford B, Haque T, Joseph A, Simonet C, Gallagher D, Budu C, Dobson R, Noyce A ( 2021 ) . HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson's disease and type 2 diabetes . MOVEMENT DISORDERS . vol. 36 , S452 - S452 .

Francis M, Haque T, Gallagher D, Budu C, Schrag A, Simonet C ( 2021 ) . Rapid blinking as an early clinical marker of Parkinson's disease . MOVEMENT DISORDERS . vol. 36 , S475 - S476 .

Simonet C, Galmes MA, Lambert C, Rees RN, Haque T, Bestwick JP, Lees AJ ( 2021 ) . Slow Motion Analysis of Repetitive Tapping (SMART) Test: Measuring Bradykinesia in Recently Diagnosed Parkinson’s Disease and Idiopathic Anosmia . Journal of Parkinson’s Disease vol. 11 , ( 4 ) 1901 - 1915 .

Simonet C, Galmes M, Lambert C, Rees R, Haque T, Bestwick J ( 2021 ) . Slow Motion Analysis of Repetitive Tapping (SMART) test: measuring of Bradykinesia in Recently Diagnosed Parkinson's disease and Idiopathic Anosmia . MOVEMENT DISORDERS . vol. 36 , S577 - S578 .

Blauwendraat C, Noyce A, Reimer A, Casey B, Riley E, Fiske B, Rizig M, Hardy J et al. ( 2021 ) . The Global Parkinson's Genetics Program (GP2) - a year's progress . MOVEMENT DISORDERS . vol. 36 , S305 - S305 .

Schumacher-Schuh F, Lim S-Y, Okunoye O, Bandres-Ciga S, Heutink P, Iwaki H, Kruger R, Mok K et al. ( 2021 ) . The Global Parkinson's Genetics Program (GP2) Underrepresented Populations Working Group . MOVEMENT DISORDERS . vol. 36 , S321 - S321 .

Blauwendraat C, Makarious MB, Leonard HL, Bandres-Ciga S, Iwaki H, Singleton AB ( 2020 ) . A population scale analysis of rare SNCA variation in the UK Biobank . Neurobiology of Disease vol. 148 ,

Jacobs BM, Smets I, Giovannoni G, Noyce A, Jokubaitis V, Dobson R ( 2020 ) . Regarding: Nicotinic acetylcholine receptors α7 and α9 modify tobacco smoke risk for multiple sclerosis . Multiple Sclerosis Journal vol. 27 , ( 8 ) 1311 - 1312 .

Bothongo PL, Jitlal M, Parry E, Foote IF, Waters S, Dobson R, Noyce AJ, Bestwick JP et al. ( 2020 ) . Ethnic and socioeconomic determinants of dementia risk: A nested case‐control study in the population of East London . Alzheimer's & Dementia vol. 16 , ( S10 )

Foote IF, Jacobs BM, Noyce AJ, Korszun A, Bhui KS, Marshall CR ( 2020 ) . Exploring the shared genetic architecture of modifiable risk factors and related endophenotypes of Alzheimer’s disease: A genomic SEM study . Alzheimer's & Dementia vol. 16 , ( S2 )

Noyce AJ ( 2020 ) . Genetic Risk of Alzheimer's Disease – Sleepless with the Enemy . Annals of Neurology vol. 89 , ( 1 ) 27 - 29 .

Iwaki H, Blauwendraat C, Leonard HL, Makarious MB, Kim JJ, Liu G, Maple‐Grødem J, Corvol J et al. ( 2020 ) . Differences in the Presentation and Progression of Parkinson's Disease by Sex . Movement Disorders vol. 36 , ( 1 ) 106 - 117 .

Auger SD, Jacobs BM, Dobson R, Marshall CR, Noyce AJ ( 2020 ) . Big data, machine learning and artificial intelligence: a neurologist’s guide . Practical Neurology vol. 21 , ( 1 ) 4 - 11 .

Auger S, Jacobs B, Dobson R, MARSHALL C, Noyce A ( 2020 ) . Navigating a world of big data, machine learning and artificial intelligence: a neurologist's guide . Practical Neurology

Cheong JL, Goh ZHK, Tanner CM, Kasten M, Noyce AJ ( 2020 ) . The Impact of COVID‐19 on Access to Parkinson's Disease Medication . Movement Disorders vol. 35 , ( 12 ) 2129 - 2133 .

Jacobs BM, Belete D, Bestwick J, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, Nalls MA et al. ( 2020 ) . Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank . Journal of Neurology Neurosurgery & Psychiatry vol. 91 , ( 10 ) 1046 - 1054 .

Williams DM, Bandres‐Ciga S, Noyce AJ, Team TAR ( 2020 ) . Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization . Annals of Neurology vol. 88 , ( 5 ) 1043 - 1047 .

Mencacci NE, Reynolds R, Ruiz SG, Vandrovcova J, Forabosco P, Sánchez-Ferrer A, Volpato V, Botía JA et al. ( 2020 ) . Dystonia genes functionally converge in specific neurons and share neurobiology with psychiatric disorders . Brain vol. 143 , ( 9 ) 2771 - 2787 .

Jacobs BM, Taylor T, Awad A, Baker D, Giovanonni G, Noyce AJ, Dobson R ( 2020 ) . Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis . Brain Communications vol. 2 , ( 2 )

Cheong JLY, de Pablo-Fernandez E, Foltynie T, Noyce AJ ( 2020 ) . The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease . Journal of Parkinson’s Disease vol. 10 , ( 3 ) 775 - 789 .

Akram N, Li H, Ben-Joseph A, Budu C, Noyce AJ ( 2020 ) . Developing and Validating a New Web-Based Tapping Test for Measuring Distal Bradykinesia in Parkinson’s Disease .

Bandres-Ciga S, Saez-Atienzar S, Kim JJ, Makarious MB, Faghri F, Diez-Fairen M, Iwaki H, Leonard H et al. ( 2020 ) . Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease . Acta Neuropathologica vol. 140 , ( 3 ) 341 - 358 .

Marini K, Mahlknecht P, Tutzer F, Stockner H, Djamshidian A, Willeit P, Kiechl S, Willeit J et al. ( 2020 ) . Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population‐Based Cohort . Movement Disorders vol. 35 , ( 9 ) 1658 - 1662 .

Williams DM, Bandres-Ciga S, Heilbron K, Team TAR ( 2020 ) . Evaluating lipid-lowering drug targets for Parkinson disease prevention with Mendelian randomization .

Belete D, Jacobs B, Schrag A, Noyce A ( 2020 ) . Exploring the Parkinson’s disease phenome in the UK Biobank population (4040) . Neurology vol. 94 , ( 15_supplement )

Iwaki H, Blauwendraat C, Leonard HL, Makarious MB, Kim JJ, Liu G, Maple-Grødem J, Pihlstrøm L et al. ( 2020 ) . Differences in the presentation and progression of Parkinson’s disease by sex .

Bestwick JP, Auger SD, Simonet C, Rees RN, Rack D, Jitlal M, Giovannoni G ( 2020 ) . Improving estimation of Parkinson’s disease risk - The enhanced PREDICT-PD algorithm .

Auger SD, Kanavou S, Lawton M, Ben‐Shlomo Y, Schrag AE, Grosset DG ( 2020 ) . Testing Shortened Versions of Smell Tests to Screen for Hyposmia in Parkinson's Disease . Movement Disorders Clinical Practice vol. 7 , ( 4 ) 394 - 398 .

Bestwick JP, Auger SD, Schrag AE, Grosset DG, Kanavou S, Cuzick J ( 2020 ) . Maximising information on smell, quantitative motor impairment and probable REM-sleep behaviour disorder in the prediction of Parkinson’s disease .

Jacobs BM, Noyce AJ, Hardy CJ, Warren JD, Marshall CR ( 2020 ) . Estimating the causal effect of hearing loss on Alzheimer’s disease: a Mendelian randomisation study .

Guelfi S, D’Sa K, Botía JA, Vandrovcova J, Reynolds RH, Zhang D, Trabzuni D, Collado-Torres L et al. ( 2020 ) . Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information . Nature Communications vol. 11 , ( 1 )

( 2020 ) . Corrigendum . Brain vol. 143 , ( 4 ) e33 - e33 .

Dobson R, Jitlal M, Marshall CR, Noyce AJ, Robson J, Cuzick J, Giovannoni G ( 2020 ) . Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk . Annals of Neurology vol. 87 , ( 4 ) 599 - 608 .

Iwaki H, Blauwendraat C, Makarious MB, Bandrés‐Ciga S, Leonard HL, Gibbs JR, Hernandez DG, Faghri F ( 2020 ) . Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score . Movement Disorders vol. 35 , ( 5 ) 774 - 780 .

Jacobs BM, Noyce AJ, Giovannoni G, Dobson R ( 2020 ) . BMI and low vitamin D are causal factors for multiple sclerosis: A Mendelian Randomization study . Neurology Neuroimmunology & Neuroinflammation vol. 7 , ( 2 )

Bandres-Ciga S, Noyce AJ, Traynor BJ ( 2020 ) . Mendelian Randomization—A Journey From Obscurity to Center Stage With a Few Potholes Along the Way . JAMA Neurology vol. 77 , ( 1 ) 7 - 8 .

Akram N, Li H, Ben-Joseph A, Budu C, Noyce A ( 2020 ) . A New Web-Based Tapping Test for Measuring Distal Bradykinesia in Parkinson's Disease . MOVEMENT DISORDERS . vol. 35 , S642 - S643 .

Marini K, Mahlknecht P, Tutzer F, Stockner H, Gasperi A, Djamshidian-Tehrani A, Willeit P, Kiechl S et al. ( 2020 ) . Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population Based Cohort . MOVEMENT DISORDERS . vol. 35 , S79 - S79 .

Goodwin G, Li H, Ismail A, Azevedo H, Schrag A, Bestwick J, Noyce A ( 2020 ) . Assessing the screening performance of three abbreviated smell tests in Parkinson's disease . MOVEMENT DISORDERS . vol. 35 , S652 - S652 .

Simonet C, Schrag A, Lees A ( 2020 ) . Emerging motor dysfunction in those at-risk of Parkinson's disease: 5-year follow-up of PREDICT-PD participants . MOVEMENT DISORDERS . vol. 35 , S85 - S85 .

Belete D, Jacobs B, Schrag A, Noyce A ( 2020 ) . Exploring the Parkinson's disease phenome in the UK Biobank population . NEUROLOGY . vol. 94 ,

Jacobs B, Noyce A, Bestwick J, Belete D, Giovannoni G, Dobson R ( 2020 ) . Gene-environment interactions in multiple sclerosis: a uk biobank study . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 367 - 367 .

Alarcón F, Maldonado J-C, Cañizares M, Molina J ( 2020 ) . Motor Dysfunction as a Prodrome of Parkinson’s Disease . Journal of Parkinson’s Disease vol. 10 , ( 3 ) 1067 - 1073 .

Belete D, Jacobs B, Bestwick J, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, Nalls M et al. ( 2020 ) . Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank . MOVEMENT DISORDERS . vol. 35 , S74 - S74 .

Kang X, Ploner A, Pedersen N, Ludvigsson J, Williams D ( 2020 ) . Predicting the effects of Tumor Necrosis Factor inhibition on the risk and age at onset of Parkinson's disease: A Mendelian randomization study . MOVEMENT DISORDERS . vol. 35 , S77 - S77 .

Simonet C, Rees R, Galmes M, Schrag A ( 2020 ) . Slow Motion Analysis of Repetitive Tapping (SMART) test: a new means to assess bradykinesia . MOVEMENT DISORDERS . vol. 35 , S666 - S666 .

Noyce A, Giovannoni G, Scheltens P, Berg D, Brown L, Dierickx K, Frisoni G, Georges J ( 2020 ) . Time matters in brain health: how can health systems respond to the growing demand for genetic testing? . MOVEMENT DISORDERS . vol. 35 , S71 - S71 .

Noyce A, Giovannoni G, Scheltens P, Berg D, Brown L, Georges J ( 2020 ) . Time matters in brain health: how should society prepare for a growing population at risk of neurodegenerative diseases? . EUROPEAN JOURNAL OF NEUROLOGY . vol. 27 , 143 - 143 .

Ben-Joseph A, Haque T, Gallagher D, Chaudhuri R ( 2020 ) . Type 2 diabetes mellitus may worsen severity of motor symptoms in people with Parkinson's disease . MOVEMENT DISORDERS . vol. 35 , S153 - S153 .

Ben-Joseph A, Marshall CR, Lees AJ, Noyce AJ ( 2019 ) . Ethnic Variation in the Manifestation of Parkinson’s Disease: A Narrative Review . Journal of Parkinson’s Disease vol. 10 , ( 1 ) 31 - 45 .

Simonet C, Schrag A, Lees AJ ( 2019 ) . The motor prodromes of parkinson’s disease: from bedside observation to large-scale application . Journal of Neurology vol. 268 , ( 6 ) 2099 - 2108 .

Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA et al. ( 2019 ) . Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies . The Lancet Neurology vol. 18 , ( 12 ) 1091 - 1102 .

Blauwendraat C, Reed X, Krohn L, Heilbron K, Bandres-Ciga S, Tan M, Gibbs JR, Hernandez DG et al. ( 2019 ) . Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia . Brain vol. 143 , ( 1 ) 234 - 248 .

Rees RN, Philpott C, Gane S, Schrag A ( 2019 ) . 139 Risk of parkinson’s in idiopathic anosmia . Journal of Neurology Neurosurgery & Psychiatry vol. 90 , ( 12 )

Bandres‐Ciga S, Ahmed S, Sabir MS, Blauwendraat C, Adarmes‐Gómez AD, Bernal‐Bernal I, Bonilla‐Toribio M, Buiza‐Rueda D et al. ( 2019 ) . The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population‐Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight . Movement Disorders vol. 34 , ( 12 ) 1851 - 1863 .

Noyce AJ, Bandres‐Ciga S, Kim J, Heilbron K, Kia D, Xue A, Lawlor DA, Smith GD et al. ( 2019 ) . The Parkinson's Disease Mendelian Randomization Research Portal . Movement Disorders vol. 34 , ( 12 ) 1864 - 1872 .

Iwaki H, Blauwendraat C, Leonard HL, Kim JJ, Liu G, Maple‐Grødem J, Corvol J, Pihlstrøm L et al. ( 2019 ) . Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts . Movement Disorders vol. 34 , ( 12 ) 1839 - 1850 .

Neligan A, Noyce AJ, Gosavi TD, Köhler S ( 2019 ) . Change in Mortality of Generalized Convulsive Status Epilepticus in High-Income Countries Over Time . JAMA Neurology vol. 76 , ( 8 ) 897 - 905 .

Neligan A, Noyce AJ, Gosavi TD, Shorvon SD ( 2019 ) . Change in Mortality of Generalized Convulsive Status Epilepticus in High-Income Countries Over Time . JAMA Neurology vol. 76 , ( 8 ) 897 - 897 .

Iwaki H, Blauwendraat C, Leonard HL, Liu G, Maple-Grødem J, Corvol J-C, Pihlstrøm L, van Nimwegen M et al. ( 2019 ) . Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts . Neurology Genetics vol. 5 , ( 4 )

Hasan H, Burrows M, Athauda DS, Hellman B, James B, Warner T, Foltynie T ( 2019 ) . The BRadykinesia Akinesia INcoordination (BRAIN) Tap Test: Capturing the Sequence Effect . Movement Disorders Clinical Practice vol. 6 , ( 6 ) 462 - 469 .

Fernández‐Santiago R, Martín‐Flores N, Antonelli F, Cerquera C, Moreno V, Bandres‐Ciga S, Manduchi E, Singleton AB et al. ( 2019 ) . SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease . Movement Disorders vol. 34 , ( 9 ) 1333 - 1344 .

Billingsley KJ, Barbosa IA, Bandrés-Ciga S, Quinn JP, Bubb VJ, Deshpande C, Botia JA, Reynolds RH et al. ( 2019 ) . Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset . npj Parkinson's Disease vol. 5 , ( 1 )

Joseph T, Auger SD, Peress L, Rack D, Cuzick J, Schrag AE ( 2019 ) . Screening performance of abbreviated versions of the UPSIT smell test . Journal of Neurology vol. 266 , ( 8 ) 1897 - 1906 .

Reynolds RH, Botía J, Nalls MA, Hardy J, Gagliano Taliun SA, Ryten M ( 2019 ) . Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability . npj Parkinson's Disease vol. 5 , ( 1 )

Blauwendraat C, Heilbron K, Vallerga CL, Bandres‐Ciga S, von Coelln R, Pihlstrøm L, Simón‐Sánchez J, Sharma M et al. ( 2019 ) . Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms . Movement Disorders vol. 34 , ( 6 ) 866 - 875 .

Heilbron K, Noyce AJ, Alipanahi B, Nalls MA ( 2019 ) . The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort . npj Parkinson's Disease vol. 5 , ( 1 )

Bandres‐Ciga S, Noyce AJ, Hemani G, Nicolas A, Calvo A, Mora G, Arosio A, Barberis M et al. ( 2019 ) . Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis . Annals of Neurology vol. 85 , ( 4 ) 470 - 481 .

Schrag A, Anastasiou Z, Ambler G, Noyce A ( 2019 ) . Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations . Movement Disorders vol. 34 , ( 4 ) 480 - 486 .

Bandres‐Ciga S, Saez‐Atienzar S, Bonet‐Ponce L, Billingsley K, Vitale D, Blauwendraat C, Gan‐Or Z, Consortium TIPDG et al. ( 2019 ) . The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease . Movement Disorders vol. 34 , ( 4 ) 460 - 468 .

Dobson R, Jitlal M, Marshall C, Noyce A, Giovannoni G ( 2019 ) . Obesity is not associated with MS in a socially and ethnically diverse population . MULTIPLE SCLEROSIS JOURNAL . vol. 25 , 49 - 49 .

Rees R, Gane S, Philpott C, Noyce A ( 2019 ) . Risk of Parkinson's in idiopathic anosmia . MOVEMENT DISORDERS . vol. 34 ,

Simonet C, Galmes MA, Schrag A ( 2019 ) . Slow-Motion Analysis of Repetitive Tapping (SMART): a pilot study of a new measurement of bradykinesia . MOVEMENT DISORDERS . vol. 34 , S926 - S926 .

Rees RN, Schrag A ( 2018 ) . The prodromes of Parkinson's disease . European Journal of Neuroscience vol. 49 , ( 3 ) 320 - 327 .

Kia DA, Sabir MS, Ahmed S, Trinh J, Bandres-Ciga S, Consortium IPDG, Noyce AJ, Kaiyrzhanov R et al. ( 2018 ) . LRP10 in α-synucleinopathies . The Lancet Neurology vol. 17 , ( 12 )

Acharya A, Basnett I, Gutteridge C ( 2018 ) . Laughter isn't always the best medicine . BMJ vol. 363 , k4579 - k4579 .

Blauwendraat C, Reed X, Kia DA, Gan-Or Z, Lesage S, Pihlstrøm L, Guerreiro R, Gibbs JR et al. ( 2018 ) . Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease . JAMA Neurology vol. 75 , ( 11 ) 1416 - 1422 .

Kia DA, Noyce AJ, White J, Speed D, Nicolas A, collaborators I, Singleton A, Nalls MA et al. ( 2018 ) . Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease . Annals of Neurology vol. 84 , ( 2 ) 191 - 199 .

Rees RN, Acharya AP, Schrag A ( 2018 ) . An early diagnosis is not the same as a timely diagnosis of Parkinson's disease . F1000Research vol. 7 , 1106 - 1106 .

De Pablo-Fernandez E, Goldacre R, Pakpoor J, Noyce AJ, Warner TT ( 2018 ) . Association between diabetes and subsequent Parkinson disease . Neurology vol. 91 , ( 2 ) e139 - e142 .

Noyce A ( 2018 ) . Remembering the man behind An Essay on the Shaking Palsy . The Lancet Neurology vol. 17 , ( 6 )

Keddie S, Adams A, Kelso ARC, Turner B, Schmierer K, Gnanapavan S, Malaspina A, Noyce AJ ( 2018 ) . No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalation . Journal of Neurology vol. 265 , ( 5 ) 1089 - 1095 .

Weil RS, Schwarzkopf DS, Bahrami B, Fleming SM, Jackson BM, Goch TJC, Saygin AP, Miller LE et al. ( 2018 ) . Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo‐perceptual deficits . Movement Disorders vol. 33 , ( 4 ) 544 - 553 .

NOYCE AJ ( 2018 ) . Assessing cognitive dysfunction in Parkinson’s: An online tool to detect visuo-perceptual deficits . Movement Disorders

Noyce AJ, Dickson J, Bestwick JP, Isaias IU, Giovannoni G, Warner TT ( 2018 ) . Dopamine reuptake transporter–single‐photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease . Movement Disorders vol. 33 , ( 3 ) 478 - 482 .

Adams-Carr KL ( 2018 ) . Predicting Parkinson's disease . Advances in Clinical Neuroscience & Rehabilitation

Osborne C, Schrag A ( 2018 ) . Prodromal Parkinson’s Disease and Biomarkers . Understanding Parkinsonism: The Clinical Perspective , Jaypee Brothers Medical Publishing

Auger S, Rack D, Bestwick J, Giovannoni G, Lees A ( 2018 ) . Risk estimation in the years preceding diagnosis of Parkinson's disease in the PREDICT-PD cohort . MOVEMENT DISORDERS . vol. 33 , S773 - S774 .

Joseph T, Auger S, Peress L, Rack D, Noyce A ( 2018 ) . Screening performance of abbreviated versions of the UPSIT smell test . MOVEMENT DISORDERS . vol. 33 , S741 - S741 .

Noyce A, Kia D, Heilbron K, Jepson J, Hemani G, Hinds D, Lawlor D, Smith GD et al. ( 2018 ) . Tendency towards being a "Morning person" increases risk of Parkinson's disease: evidence from Mendelian randomisation . MOVEMENT DISORDERS . vol. 33 , S364 - S364 .

Blauwendraat C, Kia DA, Pihlstrøm L, Gan-Or Z, Lesage S, Gibbs JR, Ding J, Alcalay RN et al. ( 2017 ) . Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease . Neurobiology of Aging vol. 64 , 159.e5 - 159.e8 .

Shribman S, Noyce A, Gnanapavan S, Lambourne J, Harrison T ( 2017 ) . Cryptococcal meningitis in apparently immunocompetent patients: association with idiopathic CD4+ lymphopenia . Practical Neurology vol. 18 , ( 2 ) 166 - 169 .

Shribman S, Hasan H, Hadavi S, Giovannoni G ( 2017 ) . The BRAIN test: a keyboard-tapping test to assess disability and clinical features of multiple sclerosis . Journal of Neurology vol. 265 , ( 2 ) 285 - 290 .

Noyce AJ, Lees A ( 2017 ) . Observations on a 2-Step Approach to Screening for Parkinson Disease . JAMA Neurology vol. 74 , ( 12 ) 1506 - 1506 .

Noyce A, Bandopadhyay R ( 2017 ) . Parkinson's Disease: Basic Pathomechanisms and a Clinical Overview . vol. 15 ,

Raciborska DD, Noyce AJ, Turner BP ( 2017 ) . Lupus myelopathy . Practical Neurologypractneurol-2017-001756 - practneurol-2017-001756 .

Lynch DS, Loh SHY, Harley J, Noyce AJ, Wood NW, Houlden H ( 2017 ) . Nonsyndromic Parkinson disease in a family with autosomal dominant optic atrophy due to OPA1 mutations . Neurology Genetics vol. 3 , ( 5 ) e188 - e188 .

Noyce AJ, Kia DA, Hemani G, Nicolas A, Price TR, De Pablo-Fernandez E, Haycock PC, Lewis PA et al. ( 2017 ) . Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study . PLOS Medicine vol. 14 , ( 6 ) e1002314 - e1002314 .

Noyce A, Kia D, Hemani G, Nicolas A, Price T, Fernandez E, Haycock P, Lewis P et al. ( 2017 ) . Increased BMI May Protect against Parkinson's Disease: Evidence From Mendelian Randomisation Study . vol. 32 ,

Magdalinou NK, Noyce AJ, Pinto R, Lindstrom E, Holmen-Larsson J, Holtta M, Blennow K, Morris HR et al. ( 2017 ) . Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics . PARKINSONISM & RELATED DISORDERS vol. 37 , 65 - 71 .

Pakpoor J, Noyce A, Goldacre R, Selkihova M, Mullin S, Goldacre M ( 2017 ) . Viral hepatitis and Parkinson disease . Neurology vol. 88 , ( 17 ) 1630 - 1633 .

Hasan H, Foltynie T, Noyce AJ ( 2017 ) . Technologies Assessing Limb Bradykinesia in Parkinson’s Disease . Journal of Parkinson’s Disease vol. 7 , ( 1 ) 65 - 77 .

Noyce AJ, R'Bibo L, Peress L, Bestwick JP, Mencacci NE, Hawkes CH, Masters JM, Lees AJ ( 2017 ) . PREDICT‐PD: An online approach to prospectively identify risk indicators of Parkinson's disease . Movement Disorders vol. 32 , ( 2 ) 219 - 226 .

Noyce A, Dickson J, Bestwick J, Isaias I, Politis M, Giovannoni G ( 2017 ) . Associations of DAT SPECT and TCS with prodromal features of Parkinson's disease: Results in PREDICT-PD participants . MOVEMENT DISORDERS . vol. 32 ,

Nagy A, Hardaker E, Bestwick J, Giovannoni G, Warner T ( 2017 ) . Cognition in the PREDICT-PD Cohort . MOVEMENT DISORDERS . vol. 32 ,

Noyce AJ, Schrag A, Masters JM ( 2016 ) . Subtle motor disturbances in PREDICT-PD participants . Journal of Neurology Neurosurgery & Psychiatry vol. 88 , ( 3 )

Lubbe SJ, Escott-Price V, Gibbs JR, Nalls MA, Bras J, Price TR, Nicolas A, Jansen IE et al. ( 2016 ) . Additional rare variant analysis in Parkinson’s disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance . Human Molecular Genetics vol. 25 , ( 24 ) 5483 - 5489 .

Hasan H, Athauda DS, Foltynie T, Warner T, Lees AJ ( 2016 ) . Objective decrement in Parkinson's disease - A new parameter for the BRAIN tap test . Movement Disorders . Conference: 20th International Congress of Parkinson's Disease and Movement Disorders ( Berlin, Germany ) from: 19/06/2016 to: 23/06/2016 , vol. 31 , S177 - S177 .

Salat D, Noyce AJ, Schrag A, Tolosa E ( 2016 ) . Challenges of modifying disease progression in prediagnostic Parkinson's disease . The Lancet Neurology vol. 15 , ( 6 ) 637 - 648 .

Mok KY, Sheerin U, Simón-Sánchez J, Salaka A, Chester L, Escott-Price V, Mantripragada K, Doherty KM et al. ( 2016 ) . Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data . The Lancet Neurology vol. 15 , ( 6 ) 585 - 596 .

Noyce AJ, Lees AJ ( 2016 ) . The prediagnostic phase of Parkinson's disease . Journal of Neurology Neurosurgery & Psychiatry vol. 87 , ( 8 ) 871 - 878 .

Masters JM, Noyce AJ, Warner TT, Proctor GB ( 2016 ) . A comprehensive characterisation of the salivary proteome of patients with Parkinson's disease . MOVEMENT DISORDERS . vol. 31 , S238 - S239 .

Noyce AJ, Schrag A, Masters J, Bestwick JP, Giovannoni G ( 2016 ) . Blinded video assessment of subtle Parkinsonian signs in PREDICT-PD participants . MOVEMENT DISORDERS . vol. 31 , S506 - S506 .

Mok KY, Sheerin U, Simon-Sanchez J, Salaka A, Chester L, Escott-Price V, Mantripragada K, Doherty KM et al. ( 2016 ) . Deletions at 22q11.2 in idiopathic Parkinson's disease: A combined analysis of GWAS data . MOVEMENT DISORDERS . vol. 31 , S221 - S222 .

R'Bibo L, Mencacci NE, Schrag A, Bestwick JP, Peress L, Masters J, Giovannoni G, Lees AJ et al. ( 2016 ) . Exploring association of GBA variants with pre-diagnostic features of PD in the PREDICT-PD cohort: A nested case-control study . MOVEMENT DISORDERS . vol. 31 , S125 - S125 .

Simonet C, Noyce AJ, Ling H ( 2016 ) . Handwriting in Parkinson's disease: Systematic review and preliminary study . MOVEMENT DISORDERS . vol. 31 , S508 - S508 .

Osborne CW, Bestwick J, Giovannoni G, Lees AJ, Schrag A ( 2016 ) . Participant feedback in the PREDICT-PD study . MOVEMENT DISORDERS . vol. 31 , S594 - S594 .

Noyce AJ ( 2015 ) . Mendelian Randomization — the Key to Understanding Aspects of Parkinson's Disease Causation? . Movement Disorders vol. 31 , ( 4 ) 478 - 483 .

Noyce A, Bestwick J, Hawkes C, Hardy J, Giovannoni G ( 2015 ) . PREDICT-PD: Identifying Risk of Parkinson's disease in the Community . MOVEMENT DISORDERS . vol. 30 , 1989 - 1989 .

Masters JM, Bestwick J, Warner TT, Proctor GB ( 2015 ) . Systematic review and meta‐analysis of salivary protein concentration in Parkinson's disease . Movement Disorders vol. 30 , ( 14 ) 1971 - 1972 .

Adams-Carr K, Schrag A, Shribman S, Lees A ( 2015 ) . CONSTIPATION PRECEDING PARKINSON'S DISEASE–META-ANALYSIS . Journal of Neurology Neurosurgery & Psychiatry . vol. 86 ,

Masters J, Noyce A, Warner T, Proctor G ( 2015 ) . ELEVATED SALIVARY DJ-1 IN PARKINSON'S DISEASE IS ASSOCIATED WITH ALTERED SALIVARY SECRETION . Journal of Neurology Neurosurgery & Psychiatry . vol. 86 ,

Adams-Carr KL, Bestwick JP, Lees A, Schrag A ( 2015 ) . Constipation preceding Parkinson's disease: a systematic review and meta-analysis . Journal of Neurology Neurosurgery & Psychiatry vol. 87 , ( 7 )

Nalls MA, McLean CY, Rick J, Eberly S, Hutten SJ, Gwinn K, Sutherland M, Martinez M et al. ( 2015 ) . Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study . The Lancet Neurology vol. 14 , ( 10 ) 1002 - 1009 .

Masters JM, Noyce AJ, Warner TT, Giovannoni G ( 2015 ) . Elevated salivary protein in Parkinson's disease and salivary DJ-1 as a potential marker of disease severity . Parkinsonism & Related Disorders vol. 21 , ( 10 ) 1251 - 1255 .

Noyce AJ, Mencacci NE, Schrag A, Bestwick JP, Giovannoni G ( 2015 ) . Web‐based assessment of Parkinson's prodromal markers identifies GBA variants . Movement Disorders vol. 30 , ( 7 ) 1002 - 1003 .

Nagy A, Noyce A, Velayos-Baeza A, Lees AJ, Warner TT ( 2015 ) . Late Emergence of Parkinsonian Phenotype and Abnormal Dopamine Transporter Scan in Chorea‐Acanthocytosis . Movement Disorders Clinical Practice vol. 2 , ( 2 ) 182 - 186 .

Adams-Carr KL, Schrag A, Shribman S, Bestwick JP ( 2015 ) . Constipation preceding Parkinson's disease - Systematic review and meta-analysis . MOVEMENT DISORDERS . vol. 30 , S149 - S149 .

Masters JM, Noyce AJ, Giovannoni G, Warner TT ( 2015 ) . Elevated salivary DJ-1 in Parkinson's disease is associated with altered salivary secretion . MOVEMENT DISORDERS . vol. 30 , S169 - S170 .

Athauda DS, Hasan H, Noyce A ( 2015 ) . Evaluating the use of the online bradykinesia-akinesia Incoordination (BRAIN) test in Parkinson's disease in "on" and "off" states . MOVEMENT DISORDERS . vol. 30 , S414 - S415 .

Magdalinou N, Ling H, Noyce A, Massey L, Paterson R, Schott J, Davagnanam I, Micallef C et al. ( 2015 ) . The visual estimation of midbrain to pons ratio combined with cerebrospinal fluid biomarkers improves the diagnostic accuracy of PSP . MOVEMENT DISORDERS . vol. 30 , S321 - S321 .

Schrag A, Horsfall L, Walters K, Noyce A ( 2014 ) . Prediagnostic presentations of Parkinson's disease in primary care: a case-control study . The Lancet Neurology vol. 14 , ( 1 ) 57 - 64 .

Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ ( 2014 ) . Bone health in Parkinson's disease: a systematic review and meta-analysis . J Neurol Neurosurg Psychiatry vol. 85 , ( 10 ) 1159 - 1166 .

Osborne C, Noyce A ( 2014 ) . AUTO-REGULATION ICP IN IIH DUE TO CHRONIC CSF LEAK . Journal of Neurology Neurosurgery & Psychiatry . vol. 85 , e4 - e4 .

Mencacci NE, Isaias IU, Reich MM, Ganos C, Plagnol V, Polke JM, Bras J, Hersheson J et al. ( 2014 ) . Parkinson's disease in GTP cyclohydrolase 1 mutation carriers . Brain vol. 137 , ( Pt 9 ) 2480 - 2492 .

Staff TPO ( 2014 ) . Correction: Bradykinesia-Akinesia Incoordination Test: Validating an Online Keyboard Test of Upper Limb Function . PLOS ONE vol. 9 , ( 8 )

Osborne C, Evanson J, Sylvester R ( 2014 ) . Rapid-onset flaccid paraplegia caused by multiple myeloma dumbbell tumour . Pract Neurol vol. 14 , ( 4 ) 268 - 269 .

Noyce A ( 2014 ) . Early clinical features of Parkinson’s disease and related disorders . The Biomedical & Life Sciences Collection vol. 2014 , ( 7 )

Shribman S, Torsney KM, Noyce AJ, Giovannoni G, Fearnley J, Dobson R ( 2014 ) . A service development study of the assessment and management of fracture risk in Parkinson's disease . J Neurol vol. 261 , ( 6 ) 1153 - 1159 .

Mencacci N, Isaias I, Reich M, Ganos C, Polke J, Bras J, Hersheson J, Stamelou M et al. ( 2014 ) . Mutations in the GCH1 Gene Are Associated with Parkinson Disease (S17.001) . Neurology vol. 82 , ( 10_supplement )

Shribman SE, Torsney K, Noyce AJ, Giovannoni G, Fearnley J, Dobson R ( 2014 ) . A service development study of the assessment and management of fracture risk in Parkinson's disease . MOVEMENT DISORDERS . vol. 29 , S192 - S192 .

Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ ( 2014 ) . A systematic review and meta-analysis of fracture risk in Parkinson's disease . MOVEMENT DISORDERS . vol. 29 , S551 - S551 .

Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ ( 2014 ) . Bone health in Parkinson's disease: A systematic review and meta-analysis . MOVEMENT DISORDERS . vol. 29 , S551 - S551 .

Noyce AJ, Nagy A, Acharya S, Hadavi S, Bestwick JP, Fearnley J ( 2014 ) . Bradykinesia-akinesia incoordination test: validating an online keyboard test of upper limb function . PLoS One vol. 9 , ( 4 )

Noyce AJ, Mencacci N, Schrag A, Giovannoni G ( 2014 ) . GBA1 and LRRK2 mutations in higher and lower risk subjects from the PREDICT-PD project . MOVEMENT DISORDERS . vol. 29 , S58 - S59 .

Nalls MA, Saad M, Noyce AJ, Keller MF, Schrag A, Bestwick JP, Traynor BJ, Morris HR et al. ( 2014 ) . Genetic comorbidities in Parkinson's disease . HUMAN MOLECULAR GENETICS vol. 23 , ( 3 ) 831 - 841 .

Mencacci NE, Isaias IU, Reich MM, Ganos C, Plagnol V, Polke JM, Stamelou M, Noyce AJ et al. ( 2014 ) . Parkinson's disease in GTP cyclohydrolase-1 mutation carriers . MOVEMENT DISORDERS . vol. 29 , S57 - S57 .

Shribman SE, Noyce AJ, Martin JE, Giovannoni G, Knowles CH ( 2014 ) . The distribution of α-synuclein in the enteric nervous system: An immunohistochemical study on colonic resections from 24 control and 4 Parkinson's disease patients . MOVEMENT DISORDERS . vol. 29 , S31 - S32 .

Nagy A, Noyce A, Lees A, Warner T ( 2014 ) . Two cases of abnormal dopamine transporter scan in chorea-acanthocytosis . MOVEMENT DISORDERS . vol. 29 , S195 - S196 .

Hunter R, Proctor G, Noyce A, Schrag A ( 2013 ) . Research into biomarkers to facilitate the early identification of Parkinson's disease: a decision analytic model to determine the feasibility and value . Trials vol. 14 , ( Suppl 1 )

Hadavi S, Shribman S, Nagy A, Acharya S, Fearnley J, Dobson R, Lees A, Giovannoni G et al. ( 2013 ) . The bradykinesia-akinesia incoordination test: a simple objective test in multiple sclerosis . J Neurol Neurosurg Psychiatry vol. 84 , ( 11 )

Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Knowles CH, Giovannoni G, Nageshwaran S, Schrag A ( 2013 ) . PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results . Journal of Neurology Neurosurgery & Psychiatry vol. 85 , ( 1 )

Dobson R, Yarnall A, Noyce AJ, Giovannoni G ( 2013 ) . Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes . Practical Neurology vol. 13 , ( 2 )

Nagy A, Acharya S, Hadavi S, Bestwick JP, Lees AJ ( 2013 ) . Bradykinesia-akinesia incoordination test: Validating an online keyboard test of upper limb function . MOVEMENT DISORDERS . vol. 28 , S114 - S114 .

Djamshidian A, O'Sullivan SS, Foltynie T, Aviles-Olmos I, Limousin P, Noyce A, Averbeck BB ( 2013 ) . Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease . MOVEMENT DISORDERS . vol. 28 , S130 - S130 .

Djamshidian A, O'Sullivan SS, Foltynie T, Aviles-Olmos I, Limousin P, Lees AJ ( 2013 ) . Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease . J Parkinsons Dis vol. 3 , ( 2 ) 139 - 144 .

Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Knowles C, Hardy J, Giovannoni G, Nageshwaran S ( 2013 ) . PREDICT-PD study: Online screening algorithm identifying Parkinson's disease risk . MOVEMENT DISORDERS . vol. 28 , S389 - S389 .

Noyce AJ, Bestwick JP, Silveira-Moriyama L, Schrag A ( 2012 ) . Meta-analysis of early nonmotor features and risk factors for Parkinson disease . Ann Neurol vol. 72 , ( 6 ) 893 - 901 .

Chan MV, Bubb KJ, Noyce A, Villar IC, Duchene J, Hobbs AJ, Scotland RS, Ahluwalia A ( 2012 ) . Distinct endothelial pathways underlie sexual dimorphism in vascular auto-regulation . Br J Pharmacol vol. 167 , ( 4 ) 805 - 817 .

Noyce AJ, Silveira-Moriyama L, Gilpin P, Howard R ( 2012 ) . Severe dysphagia as a presentation of Parkinson's disease . Mov Disord vol. 27 , ( 3 ) 457 - 458 .

Doherty KM, Silveira-Moriyama L, Nisbet A, Noyce A, Parton M ( 2012 ) . 0854 Camptocormia: what is the cause? . Journal of Neurology Neurosurgery & Psychiatry . vol. 83 ,

Noyce A, Silveira-Moriyama L, Lees AJ, Schrag A, Bestwick J, Hawkes CH ( 2012 ) . A PILOT STUDY OF AN ALGORITHM DESIGNED TO IDENTIFY PARKINSON'S DISEASE IN THE EARLY, NON-MOTOR PHASE . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 83 ,

Noyce A, Bestwick J, Hawkes CH, Knowles CH, Hardy J, Giovannoni G, Schrag A ( 2012 ) . AN ALGORITHM TO IDENTIFY INDIVIDUALS AT HIGH-RISK OF PARKINSON'S DISEASE IN THE COMMUNITY . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 83 ,

Noyce AJ, Bestwick J, Hawkes CH, Giovannoni G, Lees AJ ( 2012 ) . Risk factors and early non-motor features for Parkinson's disease: A systematic review and meta-analysis . MOVEMENT DISORDERS . vol. 27 , S4 - S4 .

Noyce A, Treacy C, Budu C, Lees AJ ( 2012 ) . THE NEW BRADYKINESIA AKINESIA INCOORDINATION (BRAIN) TEST: AN ONLINE TEST OF UPPER LIMB MOVEMENT . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 83 ,

Acharya S, Nagy A, Budu C, Treacy C, Lees AJ, Noyce AJ ( 2012 ) . The new bradykinesia akinesia incoordination (BRAIN) test: People with Parkinson's disease versus healthy controls . MOVEMENT DISORDERS . vol. 27 , S102 - S102 .

Hadavi S, Noyce AJ, Giovannoni G ( 2011 ) . Stiff person syndrome . Pract Neurol vol. 11 , ( 5 ) 272 - 282 .

Noyce AJ, Treacy C, Fearnley J, Lees AJ ( 2011 ) . The new Bradykinesia Akinesia Incoordination (BRAIN) test: Preliminary data from an online test of upper limb movement . Movement Disorders vol. 27 , ( 1 ) 157 - 158 .

Doherty KM, Noyce AJ, Silveira-Moriyama L, Nisbet A ( 2011 ) . Familial camptocormia: from dystonia to myopathy . Journal of Neurology Neurosurgery & Psychiatry vol. 83 , ( 3 )

Noyce AJ, Bestwick J, Hawkes CH, Schrag A, Giovannoni G, Silveira-Moriyama L ( 2011 ) . A pilot study of an algorithm designed to identify Parkinson's disease in the early, non-motor phase . MOVEMENT DISORDERS . vol. 26 , S54 - S54 .

Noyce AJ, Bestwick J, Hawkes CH, Knowles CH, Hardy J, Silveira-Moriyama L, Giovannoni G ( 2011 ) . An algorithm to identify individuals at high-risk of Parkinson's disease in the community . MOVEMENT DISORDERS . vol. 26 , S54 - S55 .

Hadavi SY, Noyce AJ, Webb A ( 2011 ) . POTENTIAL FOR SERIOUS UNDER-REPORTING OF PRESCRIBING ERRORS BY NEWLY-QUALIFIED DOCTORS . BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY . vol. 109 , 159 - 159 .

Noyce AJ, Gilpin P, Howard R ( 2011 ) . Severe dysphagia preceding Parkinson's disease . MOVEMENT DISORDERS . vol. 26 , S195 - S196 .

Noyce AJ, McCrae S, Gawler J ( 2010 ) . Teaching NeuroImages: microhemorrhages resulting from cranial radiotherapy in childhood . Neurology vol. 75 , ( 1 ) e2 - e3 .

Shah M, Deeb J, Fernando M, Noyce A, Visentin E, Findley LJ ( 2009 ) . Abnormality of taste and smell in Parkinson's disease . Parkinsonism Relat Disord vol. 15 , ( 3 ) 232 - 237 .

Shah M, Deeb J, Fernando M, Visentin E, Findley LJ ( 2007 ) . Taste is abnormal in Parkinson disease and suggests cortical spread . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 78 , 1024 - 1024 .

Noyce AL, Hetley RS ( 2007 ) . Perception of local rigidity due to lines in rotating random-dot textures viewed through an aperture . PERCEPTION . vol. 36 , 204 - 204 .

Shah M, Deeb J, Fernando M, Visentin E, Noyce A, Findley LJ ( 2007 ) . Taste threshold is abnormal in Parkinson's disease and suggests cortical spread . MOVEMENT DISORDERS . vol. 22 , S199 - S199 .

Shah M, Noyce A, Deeb J, Findley LJ ( 2006 ) . Chemosensory measurement in essential tremor . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 77 , 1397 - 1397 .

Shah M, Noyce A, Deeb J ( 2006 ) . Smell identification and taste threshold are normal in essential tremor . CHEMICAL SENSES . vol. 31 , E27 - E27 .

Shah M, Noyce A, Deeb J, Hawkes CH ( 2006 ) . Chemosensory measurement in essential tremor . EUR J NEUROL vol. 13 , 212 - 212 .

Noyce A, Shah M, Hawkes CH ( 2006 ) . Chemosensory measurement in essential tremor . CHEMICAL SENSES . vol. 31 , A30 - A31 .

Azoidou V, Rowsell K, Camboe E, Dey KC, Zirra A, Quah C, Boyle T, Gallagher D et al. . A Pilot Interventional Study on Feasibility and Effectiveness of the CUE1 device in Parkinson’s disease .

Blauwendraat C, Makarious MB, Leonard HL, Bandres-Ciga S, Iwaki H, Nalls MA, Noyce AJ, Singleton AB . A population scale analysis of rare SNCA variation in the UK Biobank .

Chang Y-H, Periñan MT, Wilson M, Noyce AJ . AccessPD - a ‘next generation’ registry to accelerate Parkinson’s disease research .

Jones L, Cerquera-Cleves C, Schuh AF, Makarious MB, Iwaki H, Nalls MA, Noyce AJ, Program GPG et al. . Assessment of common genetic variation in Alzheimer’s and Parkinson’s diseases reveals global distinction in population attributable risk .

Kim JJ, Bandres-Ciga S, Heilbron K, Team AR, Blauwendraat C, Noyce AJ . Bidirectional relationship between olfaction and Parkinson’s disease .

Noyce A . Cognitive impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson’s disease Parkinsonism and Related Disorders . Parkinsonism and Related Disorders

Kent DM, Leung LY, Puttock EJ, Wang AY, Luetmer PH, Kallmes DF, Nelson J, Fu S et al. . Development of Parkinson’s disease and its relationship with incidentally-discovered white matter disease and covert brain infarction in a real world cohort .

Schumacher-Schuh AF, Bieger A, Okunoye O, Mok K, Lim S-Y, Bardien S, Annuar AA, Lopes-Santos B et al. . Diversity in Parkinson’s disease genetics research: current landscape and future directions .

Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA et al. . Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk .

Jerez PÁ, Alcantud JL, de los Reyes-Ramírez L, Moore A, Ruz C, Montero FV, Rodriguez-Losada N, Saini P et al. . Exploring the Genetic and Genomic Connection Underlying Neurodegeneration with Brain Iron Accumulation and the Risk for Parkinson’s Disease .

Zirra A, Rao SC, Bestwick J, Rajalingam R, Marras C, Blauwendraat C, Mata I, Noyce AJ . Gender differences in the prevalence of Parkinson’s disease .

Reynoso A, Torricelli R, Jacobs BM, Shi J, Aslibekyan S, Kaufmann L, Noyce AJ, Heilbron K . Gene-environment interactions for Parkinson’s disease .

Jacobs BM, Noyce A, Bestwick J, Belete D, Giovannoni G, Dobson R . Gene-environment interactions in Multiple Sclerosis: a UK Biobank study .

Senkevich K, Bandres-Ciga S, Yu E, Liyanage UE, Consortium IPDG, Noyce AJ, Gan-Or Z . Genetic correlation and causality of cancers and Parkinson’s disease .

Blauwendraat C, Reed X, Krohn L, Heilbron K, Bandres-Ciga S, Tan M, Gibbs R, Hernandez DG et al. . Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia .

Iwaki H, Blauwendraat C, Leonard HL, Kim JJ, Liu G, Maple-Grødem J, Corvol J-C, Pihlstrøm L et al. . Genome-wide association study of Parkinson’s disease progression biomarkers in 12 longitudinal patients’ cohorts .

Krohn L, Heilbron K, Blauwendraat C, Reynolds RH, Yu E, Senkevich K, Rudakou U, Estiar MA et al. . Genome-wide association study of REM sleep behavior disorder identifies novel loci with distinct polygenic and brain expression effects .

Tan AH, Saffie-Awad P, Schuh AFS, Lim S-Y, Madoev H, Ahmad-Annuar A, Solle J, Wegel CE et al. . Global Perspectives on Returning Genetic Research Results in Parkinson’s Disease .

Shafieinouri M, Hong S, Schuh A, Makarious MB, Sandon R, Lee PS, Simmonds E, Iwaki H et al. . Gut-Brain Nexus: Mapping Multi-Modal Links to Neurodegeneration at Biobank Scale .

Dadu A, Satone VK, Kaur R, Hashemi SH, Leonard H, Iwaki H, Makarious MB, Billingsley K et al. . Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts .

Faghri F, Dadu A, Satone VK, Kaur R, Hashemi S, Leonard H, Iwaki H, Makarious M et al. . Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts .

Saffie-Awad P, Makarious MB, Elsayed I, Sanyaolu AO, Crea PW, Schuh AFS, Levine KS, Vitale D et al. . Insights into Ancestral Diversity in Parkinson’s Disease Risk: A Comparative Assessment of Polygenic Risk Scores .

Blauwendraat C, Iwaki H, Makarious MB, Bandres-Ciga S, Leonard H, Grenn FP, Lake J, Krohn L et al. . Investigation of Autosomal Genetic Sex Differences in Parkinson’s disease .

Estiar MA, Senkevich K, Yu E, Varghaei P, Krohn L, Bandres-Ciga S, Noyce AJ, Rouleau GA et al. . Lack of Causal Effects or Genetic Correlation between Restless Legs Syndrome and Parkinson’s Disease .

Bandres-Ciga S, Saez-Atienzar S, Kim J, Makarious M, Faghri F, Diez-Fairen M, Iwaki H, Leonard H et al. . Large-scale pathway-specific polygenic risk, transcriptomic community networks and functional inferences in Parkinson disease .

NOYCE AJ . Letter to Editor re. Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter–Deficit Prodromal Cohort. Jennings et al . JAMA Neurology

Kim JJ, Vitale D, Otani DV, Lian M, Heilbron K, Team TAR, Iwaki H, Lake J et al. . Multi-ancestry genome-wide meta-analysis in Parkinson’s disease .

. Navigating a world of big data, machine learning and artificial intelligence: a neurologist's guide . Practical Neurology

Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrøm L, Simón-Sánchez J, Schulte C et al. . Parkinson disease age of onset GWAS: defining heritability, genetic loci and a-synuclein mechanisms .

Jacobs BM, Belete D, Bestwick JP, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, Nalls MA et al. . Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank .

Toffoli M, Chohan H, Mullin S, Jesuthasan A, Yalkic S, Koletsi S, Menozzi E, Rahall S et al. . Phenotypic effect of GBA1 variants in individuals with and without Parkinson disease: the RAPSODI study .

Senkevich K, Alipour P, Chernyavskaya E, Yu E, Noyce AJ, Gan-Or Z . Potential protective link between type I diabetes and Parkinson’s disease risk and progression .

Simonet C, Bestwick J, Jitlal M, Ben-Joseph A, Marshall CR, Dobson R, Marrium S, Robson J et al. . Risk factors, early presentations, and clinical markers of Parkinson’s disease in Primary Care in a diverse UK population .

Joseph T, Auger SD, Peress L, Rack D, Cuzick J, Giovannoni G, Lees A, Schrag AE et al. . Screening performance of abbreviated versions of the UPSIT smell test .

Simonet C, Galmes M, Lambert C, Rees R, Haque T, Bestwick J, Lees A, Schrag A et al. . Slow Motion Analysis of Repetitive Tapping (SMART) test: measuring bradykinesia in recently diagnosed Parkinson’s disease and idiopathic anosmia .

Jacobs BM, Taylor T, Awad A, Baker D, Giovanonni G, Noyce A, Dobson R . Summary-data-based mendelian randomisation reveals druggable targets for multiple sclerosis .

Noyce A, Kia D, Heilbron K, Jepson J, Hemani G, Consortium TIPDG, Team TAR, Hinds D et al. . Tendency towards being a “Morning person” increases risk of Parkinson’s disease: evidence from Mendelian randomisation .

Jensen MP, Jacobs BM, Dobson R, Bandres-Ciga S, Blauwendraat C, Schrag A, Consortium TIPDG, Noyce AJ . The Association of Total and Differential Leukocyte Counts with Incident Parkinson’s Disease in UK Biobank .

Hasan H, Burrows M, Athauda DS, Hellman B, James B, Warner T, Foltynie T, Giovannoni G et al. . The BRadykinesia Akinesia INcoordination (BRAIN) tap test: capturing the sequence effect .

Zirra A, Dey KC, Camboe E, Waters S, Haque T, Huxford B, Chohan H, Donkor N et al. . The East London Parkinson’s Disease Project – A case-control study in a diverse population .

Leonard HL, Murtadha R, Martinez-Carrasco A, Muller-Nedebock A, Gil-Martinez A-L, Illarionova A, Moore A, Bustos BI et al. . The IPDGC/GP2 Hackathon - an open science event for training in data science, genomics, and collaboration using Parkinson’s disease data .

Noyce AJ, Bandres-Ciga S, Kim J, Heilbron K, Kia D, Hemani G, Xue A, Lawlor DA et al. . The Parkinson’s Disease Mendelian Randomization Research Portal .

Heilbron K, Noyce AJ, Fontanillas P, Alipanahi B, Nalls MA, Team TAR, Cannon P . The Parkinson’s Phenome: Traits Associated with Parkinson’s Disease in a Large and Deeply Phenotyped Cohort .

Jitlal M, Amirthalingam N, Karania T, Parry E, Neligan A, Dobson R, Noyce AJ, Marshall CR . The influence of socioeconomic deprivation on dementia mortality, age at death and quality of diagnosis: a nationwide death records study in England and Wales 2001-2017 .

Simonet C, Pérez-Carbonell L, Huxford BF, Chohan H, Gill A, Leschziner G, Lees AJ, Schrag A et al. . The motor anomalies seen in isolated REM sleep behavior disorder .

Ojo OO, Bandres-Ciga S, Makarious MB, Crea PW, Hernandez DG, Houlden H, Rizig M, Singleton AB et al. . The non-coding GBA1 rs3115534 variant is associated with REM sleep behavior disorder in Nigerians .

Noyce A, Dierickx K, Frisoni GB, Heilbron K, Mitchell S, Trout R, van der Flier WM, Warren-Gash C et al. . Time Matters: A Call to Protect Brain Health Via Primary Prevention Strategies .

Chohan H, Senkevich K, Patel RK, Bestwick JP, Jacobs BM, Ciga SB, Gan-Or Z, Noyce AJ . Type 2 diabetes as a determinant of Parkinson’s disease risk and progression .

Heilbron K, Jensen MP, Bandres-Ciga S, Fontanillas P, Team TAR, Blauwendraat C, Nalls MA, Singleton AB et al. . Unhealthy Behaviours and Parkinson’s Disease: A Mendelian Randomisation Study .

Coleman A, Touzé A, Farag M, Pengo M, Murphy MJ, Hassan Y, Thackeray O, Fayer K et al. . Validation of remote collection and quantification of blood Neurofilament light in neurological diseases .

Li X, Gill A, Panzarasa P, Bestwick J, Schrag A, Noyce A, De Simoni A . Web Application to Enable Online Social Interactions in a Parkinson Disease Risk Cohort: Feasibility Study and Social Network Analysis (Preprint) .